000159767212/312025Q2FALSEhttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://www.ryam.com/20250628#AccruedAndOtherCurrentLiabilitieshttp://www.ryam.com/20250628#AccruedAndOtherCurrentLiabilitieshttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2025#AccruedEnvironmentalLossContingenciesCurrent http://fasb.org/us-gaap/2025#AccruedEnvironmentalLossContingenciesNoncurrentP3Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesryam:segmentxbrli:pureiso4217:CADiso4217:EURryam:employee00015976722025-01-012025-06-2800015976722025-08-0400015976722025-03-302025-06-2800015976722024-03-312024-06-2900015976722024-01-012024-06-2900015976722025-06-2800015976722024-12-310001597672us-gaap:CommonStockMember2025-03-290001597672us-gaap:AdditionalPaidInCapitalMember2025-03-290001597672us-gaap:RetainedEarningsMember2025-03-290001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-2900015976722025-03-290001597672us-gaap:RetainedEarningsMember2025-03-302025-06-280001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-302025-06-280001597672us-gaap:CommonStockMember2025-03-302025-06-280001597672us-gaap:AdditionalPaidInCapitalMember2025-03-302025-06-280001597672us-gaap:CommonStockMember2025-06-280001597672us-gaap:AdditionalPaidInCapitalMember2025-06-280001597672us-gaap:RetainedEarningsMember2025-06-280001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-280001597672us-gaap:CommonStockMember2024-03-300001597672us-gaap:AdditionalPaidInCapitalMember2024-03-300001597672us-gaap:RetainedEarningsMember2024-03-300001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-3000015976722024-03-300001597672us-gaap:RetainedEarningsMember2024-03-312024-06-290001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-312024-06-290001597672us-gaap:CommonStockMember2024-03-312024-06-290001597672us-gaap:AdditionalPaidInCapitalMember2024-03-312024-06-290001597672us-gaap:CommonStockMember2024-06-290001597672us-gaap:AdditionalPaidInCapitalMember2024-06-290001597672us-gaap:RetainedEarningsMember2024-06-290001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-2900015976722024-06-290001597672us-gaap:CommonStockMember2024-12-310001597672us-gaap:AdditionalPaidInCapitalMember2024-12-310001597672us-gaap:RetainedEarningsMember2024-12-310001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001597672us-gaap:RetainedEarningsMember2025-01-012025-06-280001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-280001597672us-gaap:CommonStockMember2025-01-012025-06-280001597672us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-280001597672us-gaap:CommonStockMember2023-12-310001597672us-gaap:AdditionalPaidInCapitalMember2023-12-310001597672us-gaap:RetainedEarningsMember2023-12-310001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3100015976722023-12-310001597672us-gaap:RetainedEarningsMember2024-01-012024-06-290001597672us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-290001597672us-gaap:CommonStockMember2024-01-012024-06-290001597672us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-290001597672ryam:MothballingCostsMember2025-06-280001597672us-gaap:EmployeeSeveranceMember2025-06-280001597672us-gaap:OtherRestructuringMember2025-06-280001597672ryam:MothballingCostsMember2024-12-310001597672us-gaap:EmployeeSeveranceMember2024-12-310001597672ryam:MothballingCostsMember2025-01-012025-06-280001597672us-gaap:EmployeeSeveranceMember2025-01-012025-06-280001597672us-gaap:EmployeeSeveranceMember2025-03-302025-06-280001597672us-gaap:EmployeeSeveranceMember2024-03-312024-06-290001597672us-gaap:EmployeeSeveranceMember2024-01-012024-06-290001597672ryam:MothballingCostsMember2025-03-302025-06-280001597672ryam:MothballingCostsMember2024-03-312024-06-290001597672ryam:MothballingCostsMember2024-01-012024-06-290001597672us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-06-290001597672us-gaap:PensionPlansDefinedBenefitMember2024-03-312024-06-290001597672us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberryam:LumberAndNewsprintFacilitiesMember2024-06-290001597672us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberryam:LumberAndNewsprintFacilitiesMember2024-06-012024-06-290001597672us-gaap:SegmentDiscontinuedOperationsMember2025-03-302025-06-280001597672us-gaap:SegmentDiscontinuedOperationsMember2024-03-312024-06-290001597672us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberryam:LumberAndNewsprintFacilitiesMember2025-03-302025-06-280001597672us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberryam:LumberAndNewsprintFacilitiesMember2024-03-312024-06-290001597672us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberryam:LumberAndNewsprintFacilitiesMember2025-01-012025-06-280001597672us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberryam:LumberAndNewsprintFacilitiesMember2024-01-012024-06-290001597672us-gaap:TradeAccountsReceivableMember2025-06-280001597672us-gaap:TradeAccountsReceivableMember2024-12-310001597672ryam:OtherReceivablesMember2025-06-280001597672ryam:OtherReceivablesMember2024-12-310001597672srt:MaximumMember2025-01-012025-06-280001597672ryam:CanadaWarehouseLeaseMember2024-06-290001597672ryam:AssetBasedRevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-06-280001597672ryam:AssetBasedRevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-01-012025-06-280001597672ryam:AssetBasedRevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-12-310001597672ryam:A2029TermLoanMemberus-gaap:SecuredDebtMember2025-01-012025-06-280001597672ryam:A2029TermLoanMemberus-gaap:SecuredDebtMember2025-06-280001597672ryam:A2029TermLoanMemberus-gaap:SecuredDebtMember2024-12-310001597672ryam:CanadianDollarTermLoansMemberus-gaap:LoansPayableMember2025-06-280001597672ryam:CanadianDollarTermLoansMemberus-gaap:LoansPayableMember2024-12-310001597672ryam:BioNovaDebtMemberus-gaap:LoansPayableMember2025-06-280001597672ryam:BioNovaDebtMemberus-gaap:LoansPayableMember2024-12-310001597672ryam:OtherLoansMemberus-gaap:LoansPayableMember2025-06-280001597672ryam:OtherLoansMemberus-gaap:LoansPayableMember2024-12-310001597672ryam:ShortTermFactoringFacilityFranceMemberus-gaap:LineOfCreditMember2025-06-280001597672ryam:ShortTermFactoringFacilityFranceMemberus-gaap:LineOfCreditMember2024-12-310001597672ryam:PortAngelesWashingtonMember2025-01-012025-03-290001597672srt:MinimumMemberryam:PortAngelesWashingtonMember2025-03-290001597672srt:MaximumMemberryam:PortAngelesWashingtonMember2025-03-290001597672ryam:AugustaGeorgiaMember2025-01-012025-03-290001597672ryam:BioNovaMemberryam:SWENImpactFundForTransition3Member2024-11-012024-11-300001597672ryam:BioNovaMemberryam:SWENImpactFundForTransition3Member2024-11-3000015976722024-11-300001597672us-gaap:FairValueInputsLevel3Member2024-12-310001597672us-gaap:FairValueInputsLevel3Member2025-03-302025-06-280001597672us-gaap:FairValueInputsLevel3Member2025-01-012025-06-280001597672us-gaap:FairValueInputsLevel3Member2025-06-280001597672us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:FairValueInputsLevel3Member2025-06-280001597672us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:FairValueInputsLevel3Member2024-12-310001597672ryam:MeasurementInputWeightedAverageCostOfCapitalMemberus-gaap:FairValueInputsLevel3Member2025-06-280001597672ryam:MeasurementInputWeightedAverageCostOfCapitalMemberus-gaap:FairValueInputsLevel3Member2024-12-310001597672us-gaap:CarryingReportedAmountFairValueDisclosureMember2025-06-280001597672us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001597672us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2025-06-280001597672us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2024-12-310001597672ryam:BioNovaMembersrt:ScenarioForecastMemberryam:SWENImpactFundForTransition3Member2025-12-310001597672ryam:BioNovaMembersrt:ScenarioForecastMemberryam:SWENImpactFundForTransition3Member2025-01-012025-12-310001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-06-280001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-06-290001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-01-012025-06-280001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-01-012024-06-290001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2025-01-012025-06-280001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2024-01-012024-06-290001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-06-280001597672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-290001597672us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2024-12-310001597672us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2023-12-310001597672us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2025-01-012025-06-280001597672us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2024-01-012024-06-290001597672us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2025-06-280001597672us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2024-06-290001597672us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001597672us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001597672us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-06-280001597672us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-06-290001597672us-gaap:AccumulatedTranslationAdjustmentMember2025-06-280001597672us-gaap:AccumulatedTranslationAdjustmentMember2024-06-290001597672us-gaap:EmployeeStockOptionMember2025-03-302025-06-280001597672us-gaap:EmployeeStockOptionMember2024-03-312024-06-290001597672us-gaap:EmployeeStockOptionMember2025-01-012025-06-280001597672us-gaap:EmployeeStockOptionMember2024-01-012024-06-290001597672ryam:PerformanceSharesAndRestrictedStockMember2025-03-302025-06-280001597672ryam:PerformanceSharesAndRestrictedStockMember2024-03-312024-06-290001597672ryam:PerformanceSharesAndRestrictedStockMember2025-01-012025-06-280001597672ryam:PerformanceSharesAndRestrictedStockMember2024-01-012024-06-290001597672us-gaap:EmployeeStockOptionMember2025-03-302025-06-280001597672us-gaap:EmployeeStockOptionMember2024-03-312024-06-290001597672us-gaap:EmployeeStockOptionMember2025-01-012025-06-280001597672us-gaap:EmployeeStockOptionMember2024-01-012024-06-290001597672ryam:PerformanceSharesAndRestrictedStockMember2025-03-302025-06-280001597672ryam:PerformanceSharesAndRestrictedStockMember2024-03-312024-06-290001597672ryam:PerformanceSharesAndRestrictedStockMember2025-01-012025-06-280001597672ryam:PerformanceSharesAndRestrictedStockMember2024-01-012024-06-290001597672us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-06-280001597672srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2025-01-012025-06-280001597672us-gaap:PerformanceSharesMember2025-01-012025-06-280001597672srt:MinimumMemberus-gaap:PerformanceSharesMember2025-01-012025-06-280001597672srt:MaximumMemberus-gaap:PerformanceSharesMember2025-01-012025-06-280001597672us-gaap:PerformanceSharesMember2025-03-012025-03-290001597672us-gaap:RestrictedStockUnitsRSUMember2024-12-310001597672us-gaap:PerformanceSharesMember2024-12-310001597672us-gaap:RestrictedStockUnitsRSUMember2025-06-280001597672us-gaap:PerformanceSharesMember2025-06-280001597672us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-06-280001597672us-gaap:PensionPlansDefinedBenefitMember2025-03-302025-06-280001597672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-03-302025-06-280001597672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-03-312024-06-290001597672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-06-280001597672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-06-290001597672us-gaap:ForeignCountryMemberus-gaap:CanadaRevenueAgencyMember2025-03-302025-06-280001597672ryam:DisallowedInterestDeductionsMemberus-gaap:DomesticCountryMember2025-06-280001597672ryam:DisallowedInterestDeductionsMemberus-gaap:DomesticCountryMember2024-12-310001597672us-gaap:OperatingSegmentsMemberryam:CelluloseSpecialtiesMember2025-03-302025-06-280001597672us-gaap:OperatingSegmentsMemberryam:BiomaterialsMember2025-03-302025-06-280001597672us-gaap:OperatingSegmentsMemberryam:CelluloseCommoditiesMember2025-03-302025-06-280001597672us-gaap:OperatingSegmentsMemberryam:PaperboardMember2025-03-302025-06-280001597672us-gaap:OperatingSegmentsMemberryam:HighYieldPulpMember2025-03-302025-06-280001597672ryam:CorporateAndEliminationsMember2025-03-302025-06-280001597672us-gaap:OperatingSegmentsMemberryam:CelluloseSpecialtiesMember2024-03-312024-06-290001597672us-gaap:OperatingSegmentsMemberryam:BiomaterialsMember2024-03-312024-06-290001597672us-gaap:OperatingSegmentsMemberryam:CelluloseCommoditiesMember2024-03-312024-06-290001597672us-gaap:OperatingSegmentsMemberryam:PaperboardMember2024-03-312024-06-290001597672us-gaap:OperatingSegmentsMemberryam:HighYieldPulpMember2024-03-312024-06-290001597672ryam:CorporateAndEliminationsMember2024-03-312024-06-290001597672us-gaap:OperatingSegmentsMemberryam:CelluloseSpecialtiesMember2025-01-012025-06-280001597672us-gaap:OperatingSegmentsMemberryam:BiomaterialsMember2025-01-012025-06-280001597672us-gaap:OperatingSegmentsMemberryam:CelluloseCommoditiesMember2025-01-012025-06-280001597672us-gaap:OperatingSegmentsMemberryam:PaperboardMember2025-01-012025-06-280001597672us-gaap:OperatingSegmentsMemberryam:HighYieldPulpMember2025-01-012025-06-280001597672ryam:CorporateAndEliminationsMember2025-01-012025-06-280001597672us-gaap:OperatingSegmentsMemberryam:CelluloseSpecialtiesMember2024-01-012024-06-290001597672us-gaap:OperatingSegmentsMemberryam:BiomaterialsMember2024-01-012024-06-290001597672us-gaap:OperatingSegmentsMemberryam:CelluloseCommoditiesMember2024-01-012024-06-290001597672us-gaap:OperatingSegmentsMemberryam:PaperboardMember2024-01-012024-06-290001597672us-gaap:OperatingSegmentsMemberryam:HighYieldPulpMember2024-01-012024-06-290001597672ryam:CorporateAndEliminationsMember2024-01-012024-06-290001597672us-gaap:OperatingSegmentsMemberryam:CelluloseSpecialtiesMember2025-06-280001597672us-gaap:OperatingSegmentsMemberryam:CelluloseSpecialtiesMember2024-12-310001597672us-gaap:OperatingSegmentsMemberryam:BiomaterialsMember2025-06-280001597672us-gaap:OperatingSegmentsMemberryam:BiomaterialsMember2024-12-310001597672us-gaap:OperatingSegmentsMemberryam:CelluloseCommoditiesMember2025-06-280001597672us-gaap:OperatingSegmentsMemberryam:CelluloseCommoditiesMember2024-12-310001597672us-gaap:OperatingSegmentsMemberryam:PaperboardMember2025-06-280001597672us-gaap:OperatingSegmentsMemberryam:PaperboardMember2024-12-310001597672us-gaap:OperatingSegmentsMemberryam:HighYieldPulpMember2025-06-280001597672us-gaap:OperatingSegmentsMemberryam:HighYieldPulpMember2024-12-310001597672us-gaap:CorporateNonSegmentMember2025-06-280001597672us-gaap:CorporateNonSegmentMember2024-12-310001597672ryam:CelluloseSpecialtiesAndCommodityProductsMember2025-06-280001597672ryam:CelluloseSpecialtiesAndCommodityProductsMember2024-12-310001597672us-gaap:CorporateNonSegmentMember2025-01-012025-06-280001597672us-gaap:CorporateNonSegmentMember2024-01-012024-06-290001597672ryam:CelluloseSpecialtiesAndCommodityProductsMember2025-01-012025-06-280001597672ryam:CelluloseSpecialtiesAndCommodityProductsMember2024-01-012024-06-290001597672us-gaap:SuretyBondMember2025-06-280001597672ryam:LignoTechFloridaMember2025-06-280001597672ryam:LignoTechFloridaMemberryam:BorregaardASAMember2025-06-280001597672ryam:LignoTechFloridaMemberus-gaap:PaymentGuaranteeMember2025-06-280001597672ryam:JesupPlantMemberus-gaap:SubsequentEventMember2025-06-30

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 28, 2025


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-36285

RAYONIER ADVANCED MATERIALS INC.

Incorporated in the State of Delaware

I.R.S. Employer Identification No.: 46-4559529

Principal Executive Office:

1301 RIVERPLACE BOULEVARD, SUITE 2300

JACKSONVILLE, FL 32207

Telephone Number: (904) 357-4600

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of exchange on which registered

Common stock, par value $0.01 per share

RYAM

New York Stock Exchange

Securities to be registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

The registrant had 67,000,882 shares of common stock outstanding as of August 4, 2025.

Table of Contents


			Page
Part I. Financial Information
Item 1. Financial Statements (Unaudited)
Condensed Consolidated Statements of Operations			1
Condensed Consolidated Statements of Comprehensive Income (Loss)			2
Condensed Consolidated Balance Sheets			3
Condensed Consolidated Statements of Stockholders’ Equity			4
Condensed Consolidated Statements of Cash Flows			5
Notes to Condensed Consolidated Financial Statements			6
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations			22
Item 3. Quantitative and Qualitative Disclosures about Market Risk			37
Item 4. Controls and Procedures			38

Part II. Other Information
Item 1. Legal Proceedings			39
Item 1A. Risk Factors			39
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			39
Item 5. Other Information			39
Item 6. Exhibits			40

Signature			41

Table of Contents

Glossary

The following terms and abbreviations appearing in the text of this report have the meanings indicated below.


2024 Form 10-K			RYAM Annual Report on Form 10-K for the year ended December 31, 2024



2029 Term Loan			$700 million original aggregate principal amount of variable rate term loan entered into October 2024, maturing October 2029
ABL Credit Facility			$175 million 5-year senior secured asset-based revolving credit facility, as amended, maturing November 2029
AETR			Annual effective tax rate
AGE			Altamaha Green Energy LLC
ASC			Accounting Standards Codification
ASU			Accounting Standards Update
AOCI			Accumulated other comprehensive income (loss)
BioNova			RYAM BioNova S.A.S., a French simplified joint-stock company and a RYAM subsidiary in which SWEN holds a redeemable noncontrolling interest
BioNova Term Loan			€37 million aggregate principal amount of variable rate term loans entered into November 2024, maturing November 2031 and November 2032
CAD			Canadian dollar

CEWS			Canada Emergency Wage Subsidy

DTA			Deferred tax asset
EBITDA			Earnings before interest, taxes, depreciation and amortization
ERP			Enterprise Resource Planning
eSAF			Electrofuel Sustainable Aviation Fuel
Exchange Act			Securities Exchange Act of 1934, as amended
FASB			Financial Accounting Standards Board
Financial Statements			Unaudited condensed consolidated financial statements included in Part I Item 1 of this Quarterly Report on Form 10-Q
GAAP			United States generally accepted accounting principles


Georgia EPD			Georgia Environmental Protection Division
GRAS			Generally Recognized As Safe
LTF			LignoTech Florida LLC
MT			Metric ton
OPEB			Other post-employment benefits
RCRA			Resource Conservation and Recovery Act
ROU			Right-of-use
RYAM, the Company, our, we, us			Rayonier Advanced Materials Inc. and its consolidated subsidiaries
SAF			Sustainable Aviation Fuel
SEC			United States Securities and Exchange Commission
SG&A			Selling, general and administrative expense
SOFR			Secured Overnight Financing Rate
SWEN			SWEN Impact Fund for Transition 3
TSR			Total shareholder return
U.S.			United States of America


USMCA			United States-Mexico-Canada Agreement
Washington DOE			Washington Department of Ecology
Washington MTCA			Washington Model Toxics Control Act

Table of Contents

Part I. Financial Information

Item 1. Financial Statements

Rayonier Advanced Materials Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(in thousands, except per share amounts)


	Three Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Net sales	$	340,048	$	419,045	$	696,015	$	806,701
Cost of sales	(316,407)		(370,736)		(648,320)		(721,631)
Gross margin	23,641		48,309		47,695		85,070
Selling, general and administrative expense	(17,965)		(21,809)		(41,224)		(42,884)
Foreign exchange gain (loss)	(3,713)		558		(4,821)		3,469

Indefinite suspension charges (Note 2)	(229)		(6,626)		(634)		(6,626)
Environmental remediation expense	(1,312)		(1,384)		(14,459)		(2,018)
Other operating income (expense), net	(1,761)		9,149		(2,989)		8,261
Operating income (loss)	(1,339)		28,197		(16,432)		45,272
Interest expense	(23,694)		(21,270)		(47,297)		(42,125)
Components of pension and OPEB, excluding service costs (Note 15)	673		197		1,305		1,117

Other income (expense), net	(1,800)		651		(908)		1,921
Income (loss) from continuing operations before income tax	(26,160)		7,775		(63,332)		6,185
Income tax (expense) benefit (Note 16)	(339,202)		849		(333,610)		1,321
Equity in loss of equity method investment	(487)		(451)		(859)		(903)
Income (loss) from continuing operations	(365,849)		8,173		(397,801)		6,603
Income from discontinued operations, net of tax (Note 3)	2,670		3,217		2,670		3,217
Net income (loss)	(363,179)		11,390		(395,131)		9,820
Net income attributable to redeemable noncontrolling interest (Note 11)	18		—		36		—
Net income (loss) attributable to RYAM	$	(363,197)	$	11,390	$	(395,167)	$	9,820


Basic and Diluted earnings per common share (Note 13)
Income (loss) from continuing operations	$	(5.48)	$	0.12	$	(5.99)	$	0.10
Income from discontinued operations	0.04		0.05		0.04		0.05
Net income (loss)	$	(5.44)	$	0.17	$	(5.95)	$	0.15

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

Rayonier Advanced Materials Inc.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

(in thousands)


	Three Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Net income (loss)	$	(363,179)	$	11,390	$	(395,131)	$	9,820
Other comprehensive income (loss), net of tax (Note 12):
Foreign currency translation adjustment	16,711		(2,007)		24,389		(6,488)
Unrealized gain on derivative instruments	29		39		61		80
Net (loss) on employee benefit plans	(98)		2,462		(198)		2,448
Total other comprehensive income (loss)	16,642		494		24,252		(3,960)
Comprehensive income (loss)	(346,537)		11,884		(370,879)		5,860
Comprehensive income attributable to redeemable noncontrolling interest	937		—		1,363		—
Comprehensive income (loss) attributable to RYAM	$	(347,474)	$	11,884	$	(372,242)	$	5,860

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

Rayonier Advanced Materials Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(in thousands, except share and par value amounts)


	June 28, 2025		December 31, 2024
Assets
Current assets
Cash and cash equivalents	$	70,679	$	125,222
Accounts receivable, net (Note 4)	152,583		213,972
Inventory (Note 5)	233,167		208,003
Income tax receivable	900		2,637
Prepaid and other current assets	82,474		51,127
Total current assets	539,803		600,961

Property, plant and equipment (net of accumulated depreciation of $1,938,049 and $1,891,599, respectively)	1,042,714		1,018,583
Deferred tax assets	15,369		349,500
Intangible assets, net	6,900		10,404
Other assets	150,182		150,209
Total assets	$	1,754,968	$	2,129,657

Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Equity
Current liabilities
Accounts payable	$	189,607	$	196,249
Accrued and other current liabilities (Note 7)	146,918		170,785
Debt due within one year (Note 8)	25,342		23,379
Current environmental liabilities (Note 9)	9,764		9,749
Total current liabilities	371,631		400,162

Long-term debt (Note 8)	720,352		706,444
Non-current environmental liabilities (Note 9)	172,117		160,466
Pension and other postretirement benefits (Note 15)	75,966		77,239
Deferred tax liabilities	14,840		13,685
Other liabilities	44,989		47,273

Commitments and contingencies (Note 18)

Redeemable noncontrolling interest (Note 11)	12,755		10,503

Stockholders’ Equity
Common stock: 140,000,000 shares authorized at $0.01 par value, 67,000,882 and 65,966,881 issued and outstanding, respectively	670		660
Additional paid-in capital	425,530		425,303
Retained earnings (deficit)	(62,465)		333,591
Accumulated other comprehensive loss (Note 12)	(21,417)		(45,669)
Total stockholders’ equity	342,318		713,885
Total liabilities, redeemable noncontrolling interest and stockholders’ equity	$	1,754,968	$	2,129,657

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

Rayonier Advanced Materials Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

(in thousands, except share data)


	Common Stock			Additional Paid-in Capital		Retained Earnings (Deficit)		Accumulated Other Comprehensive Loss		Total Stockholders’ Equity
	Shares	Par Value
Three months ended June 28, 2025
Balance at March 29, 2025	66,754,665	$	668	$	424,262	$	301,213	$	(38,059)	$	688,084
Net loss attributable to RYAM	—	—		—		(363,197)		—		(363,197)
Other comprehensive income, net of tax	—	—		—		—		16,642		16,642
Issuance of common stock under incentive stock plans	287,728	2		(2)		—		—		—
Stock-based compensation	—	—		1,450		—		—		1,450
Repurchase of common stock(a)	(41,511)	—		(180)		—		—		(180)
Redeemable noncontrolling interest adjustment to redemption value	—	—		—		(481)		—		(481)
Balance at June 28, 2025	67,000,882	$	670	$	425,530	$	(62,465)	$	(21,417)	$	342,318

Three months ended June 29, 2024
Balance at March 30, 2024	65,554,837	$	655	$	420,448	$	371,018	$	(50,371)	$	741,750
Net income attributable to RYAM	—	—		—		11,390		—		11,390
Other comprehensive income, net of tax	—	—		—		—		494		494
Issuance of common stock under incentive stock plans	378,301	4		(4)		—		—		—
Stock-based compensation	—	—		1,690		—		—		1,690
Repurchase of common stock(a)	(43,045)	—		(190)		—		—		(190)

Balance at June 29, 2024	65,890,093	$	659	$	421,944	$	382,408	$	(49,877)	$	755,134

Six months ended June 28, 2025
Balance at December 31, 2024	65,966,881	$	660	$	425,303	$	333,591	$	(45,669)	$	713,885
Net loss attributable to RYAM	—	—		—		(395,167)		—		(395,167)
Other comprehensive income, net of tax	—	—		—		—		24,252		24,252
Issuance of common stock under incentive stock plans	1,450,938	14		(14)		—		—		—
Stock-based compensation	—	—		3,255		—		—		3,255
Repurchase of common stock(a)	(416,937)	(4)		(3,014)		—		—		(3,018)
Redeemable noncontrolling interest adjustment to redemption value	—	—		—		(889)		—		(889)
Balance at June 28, 2025	67,000,882	$	670	$	425,530	$	(62,465)	$	(21,417)	$	342,318

Six months ended June 29, 2024
Balance at December 31, 2023	65,393,014	$	654	$	419,122	$	372,588	$	(45,917)	$	746,447
Net income attributable to RYAM	—	—		—		9,820		—		9,820
Other comprehensive loss, net of tax	—	—		—		—		(3,960)		(3,960)
Issuance of common stock under incentive stock plans	621,834	6		(6)		—		—		—
Stock-based compensation	—	—		3,470		—		—		3,470
Repurchase of common stock(a)	(124,755)	(1)		(642)		—		—		(643)

Balance at June 29, 2024	65,890,093	$	659	$	421,944	$	382,408	$	(49,877)	$	755,134

(a)Repurchased to satisfy tax withholding requirements related to the issuance of stock under the Company’s incentive stock plans.

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

Rayonier Advanced Materials Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(in thousands)


	Six Months Ended
	June 28, 2025		June 29, 2024
Operating activities
Net income (loss)	$	(395,131)	$	9,820
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Income from discontinued operations	(2,670)		(3,217)
Depreciation and amortization	62,438		66,794


Stock-based compensation expense	3,255		3,470

Deferred income tax expense (benefit)	332,705		(955)
Increase in environmental liabilities	14,406		1,785


Change in fair value of put option liability	1,052		—
Net periodic benefit cost of pension and other postretirement plans	1,274		2,223
Unrealized (gain) loss on foreign currency	4,343		(2,669)
Loss on disposal of property, plant and equipment	646		1,637
Other	4,078		4,343
Changes in operating assets and liabilities:
Accounts receivable	66,487		(9,708)

Inventory	(20,604)		(18,914)
Accounts payable	1,786		3,934
Accrued and other current liabilities	(26,789)		4,721
Duty refund rights	—		40,111
Other	(33,732)		89
Contributions to pension and other postretirement plans	(4,106)		(4,606)



Cash provided by operating activities	9,438		98,858

Investing activities
Capital expenditures, net of proceeds	(74,980)		(58,020)



Cash used in investing activities	(74,980)		(58,020)

Financing activities
Borrowings of long-term debt	155,750		222,178
Repayments of long-term debt	(149,500)		(220,235)
Short-term financing, net	(2,319)		(532)
Debt issuance costs	—		(1,875)


Repurchase of common stock	(3,018)		(643)

Cash provided by (used in) financing activities	913		(1,107)

Net increase (decrease) in cash and cash equivalents	(64,629)		39,731
Net effect of foreign exchange on cash and cash equivalents	10,086		(1,353)
Balance, beginning of period	125,222		75,768
Balance, end of period	$	70,679	$	114,146

Supplemental cash flow information:
Interest paid	$	(34,208)	$	(43,793)
Income taxes refunded, net	231		4,760
Capital assets purchased on account	29,851		33,804

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

1. Nature of Operations and Basis of Presentation

Nature of Operations

RYAM is a global leader in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The Company’s specialized assets also produce bioelectricity, biomaterials, including biofuels, lignin and tall oil soap, and commodity fluff, viscose and paper pulp.

Additionally, RYAM produces a unique, lightweight multi-ply paperboard product and a bulky, high-yield pulp product. The Company’s paperboard is used for production in the commercial printing, lottery ticket and high-end packaging sectors. The Company’s high-yield pulp is used by paperboard producers as well as in traditional printing, writing and specialty paper manufacturing.

Basis of Presentation

The Financial Statements and notes thereto have been prepared in accordance with GAAP for interim financial information and in accordance with the rules and regulations of the SEC. In the opinion of management, the Financial Statements and notes reflect all adjustments, including all normal recurring adjustments, necessary for a fair presentation of the results of operations, financial position and cash flows for the periods presented. The December 31, 2024 consolidated balance sheet was derived from audited annual financial statements but does not contain all the footnote disclosures from the audited annual financial statements. These Financial Statements and notes should be read in conjunction with the consolidated financial statements and supplementary data included in the Company’s 2024 Form 10-K.

As a result of the sale of its lumber and newsprint assets in August 2021, the Company presents the historical results for those operations, and any subsequent directly associated impacts, as discontinued operations. Unless otherwise stated, information in these notes to condensed consolidated financial statements relates to continuing operations. See Note 3—Discontinued Operations for further information on the sale.

New Segment Structure

In the first quarter of 2025, the Company reorganized its High Purity Cellulose operating segment as a result of changes in its internal operating model, significant developments in its Biomaterials strategy and a successful launch of an enterprise reporting system that significantly enhances the Company’s financial reporting and costing capabilities. Specifically, the Company determined, in light of these new developments and capabilities, that the performance and outlook of the High Purity Cellulose business will be better managed as three separate businesses: Cellulose Specialties, Cellulose Commodities and a new Biomaterials business. No changes were made to the composition of the Paperboard and High-Yield Pulp operating segments. As a result of this reorganization, the Company now operates in five operating segments: Cellulose Specialties, Biomaterials, Cellulose Commodities, Paperboard and High-Yield Pulp. Prior period segment results have been recast to align with this new segment reporting structure. See Note 17—Segments for further information.

Recent Accounting Developments

Accounting Standards Updates Implemented

In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires enhanced annual income tax disclosures, primarily through changes to the rate reconciliation and income taxes paid information. The Company is adopting ASU 2023-09 for the fiscal year ending December 31, 2025 on a prospective basis. The adoption of this ASU has no impact on the Company’s interim Financial Statements and related disclosures.

In August 2023, the FASB issued ASU 2023-05 “Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement,” which provides specific guidance on how a joint venture, upon formation, should recognize and initially measure assets contributed and liabilities assumed. The Company adopted ASU 2023-05 on January 1, 2025 and it will be applied on a prospective basis to all joint ventures with a formation date on or after January 1, 2025. The adoption of this ASU had no impact to the Company’s Financial Statements.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

Subsequent Events

On July 4, 2025, the United States enacted tax reform legislation resulting in significant modifications to existing law. The most significant impacts to the Company are changes to IRC §163(j) interest deductibility, immediate expensing of capital spend in the U.S., immediate deductions of R&D expenditures and foreign tax regime changes. The Company is currently evaluating the impact of this new legislation on its consolidated financial statements.

2. Indefinite Suspension of Operations

In July 2024, the Company indefinitely suspended operations at its Temiscaming cellulose plant. The Temiscaming paperboard and high-yield pulp plants that support the Company’s Paperboard and High-Yield Pulp operating segments continue to operate at full capacity. The Temiscaming cellulose plant was idled in a safe and environmentally sound manner, and the Company will assess, on at least an annual basis, the possibility of restarting the Temiscaming cellulose plant.

Indefinite suspension of operations activities began in July 2024 and were mostly completed in the prior year. Since the start of the indefinite suspension in 2024, the Company has incurred total one-time operating charges of $17 million, including $6 million of mothballing costs, $6 million of severance and other employee costs and $5 million of other costs. While most cash costs associated with the indefinite suspension of operations were paid in the third and fourth quarters of 2024, severance and other indefinite suspension costs are expected to be paid over a period of time. Remaining one-time charges to be incurred are not expected to be material.

The following table presents the accrued liability balance activity related to the indefinite suspension during the six months ended June 28, 2025:


	Mothballing Costs		Severance and Other Employee Costs		Total
Balance at December 31, 2024	$	977	$	5,010	$	5,987
Charges incurred	719		(85)		634
Payments	(1,696)		(2,895)		(4,591)
Balance at June 28, 2025	$	—	$	2,030	$	2,030

The following table presents total indefinite suspension charges incurred by cost type:


	Three Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Severance and other employee costs(a)	$	—	$	6,206	$	(85)	$	6,206
Mothballing costs	229		420		719		420
Indefinite suspension charges	$	229	$	6,626	$	634	$	6,626

(a)Included a $1 million loss on pension curtailment charges during the quarter and six months ended June 29, 2024 associated with early retirements driven by the indefinite suspension of operations. See Note 15—Employee Benefit Plans for further information.

Charges incurred during the periods presented were recorded to the Cellulose Commodities segment in “indefinite suspension charges” in the condensed consolidated statements of operations.

3. Discontinued Operations

In August 2021, the Company completed the sale of its lumber and newsprint facilities and certain related assets located in Canada. As part of the sale of the lumber assets, the Company retained all refund rights and obligations, including interest, to softwood lumber duties generated or incurred through the closing date of the sale. In June 2024, the Company sold these refund rights, including all accrued interest, for $39 million, with the opportunity for additional sale proceeds in the future contingent upon the timing and terms of the ultimate outcome of the trade dispute between the USDOC and Canada. The Company recorded a pre-tax loss of $1 million on the sale.

During the quarters ended June 28, 2025 and June 29, 2024, the Company recognized $4 million and $5 million of pre-tax income related to CEWS benefit claims deferred since 2021. See Note 7—Accrued and Other Current Liabilities for further information.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

Income from discontinued operations was comprised of the following:


	Three Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024



Loss on sale of duty refund rights	$	—	$	(890)	$	—	$	(890)
Other operating income	3,632		5,267		3,632		5,267
Operating income	3,632		4,377		3,632		4,377


Income from discontinued operations before income tax	3,632		4,377		3,632		4,377
Income tax expense	(962)		(1,160)		(962)		(1,160)
Income from discontinued operations, net of tax	$	2,670	$	3,217	$	2,670	$	3,217

4. Accounts Receivable, Net

Accounts receivable, net included the following:


	June 28, 2025		December 31, 2024
Accounts receivable, trade	$	132,474	$	191,091
Accounts receivable, other(a)	20,863		23,938
Allowance for credit loss	(754)		(1,057)
Accounts receivable, net	$	152,583	$	213,972

(a)Consists primarily of value-added/consumption taxes, grants receivable and accrued billings due from government agencies.

5. Inventory

Inventory included the following:


	June 28, 2025		December 31, 2024
Finished goods	$	171,720	$	156,407
Work-in-progress	7,204		5,034
Raw materials	49,170		40,234
Manufacturing and maintenance supplies	5,073		6,328
Inventory	$	233,167	$	208,003

6. Leases

The Company’s operating and finance leases are primarily for corporate offices, warehouse space, rail cars and equipment. As of June 28, 2025, the Company’s leases have remaining lease terms of less than one year to 11.4 years, with standard renewal and termination options available at the Company’s discretion. Certain equipment leases have purchase options at the end of the lease term that are not included in the ROU assets, as it is not reasonably certain that the Company will exercise such options. Short-term leases with an initial term of 12 months or less are not recorded in the condensed consolidated balance sheets. The Company’s lease agreements do not contain any material residual value guarantees or restrictive covenants. The Company uses its incremental borrowing rate to determine the present value of lease payments unless the lease provides an implicit or explicit interest rate.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

Financial and other information related to the Company’s operating and finance leases follow:


	Three Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Operating lease cost	$	2,578	$	2,136	$	5,110	$	3,802

Finance lease cost
Amortization of ROU assets	116		107		229		213
Interest	13		22		29		45
Total lease cost	$	2,707	$	2,265	$	5,368	$	4,060


	Balance Sheet Location	June 28, 2025		December 31, 2024
Operating leases
ROU assets	Other assets	$	28,392	$	31,112
Lease liabilities, current	Accrued and other current liabilities	8,218		7,604
Lease liabilities, non-current	Other liabilities	21,503		24,035

Finance leases
ROU assets	Property, plant and equipment, net	$	524	$	709
Lease liabilities	Long-term debt	693		921


	Six Months Ended
	June 28, 2025		June 29, 2024
Operating cash flows - cash paid for amounts included in the measurement of operating lease liabilities	$	5,133	$	3,799
Operating lease ROU assets obtained in exchange for lease liabilities(a)	770		18,092

(a)During the six months ended June 29, 2024, the Company recorded an ROU asset and corresponding lease liability of $14 million related to a new warehouse lease agreement in Canada.

Finance lease cash flows were immaterial during each of the six months ended June 28, 2025 and June 29, 2024.


	June 28, 2025		December 31, 2024
Operating leases
Weighted average remaining lease term (in years)	4.3		4.6
Weighted average discount rate	8.3	%	8.2	%

Finance leases
Weighted average remaining lease term (in years)	1.4		1.8
Weighted average discount rate	7.0	%	7.0	%

Operating lease maturities as of June 28, 2025 were as follows:


Remainder of 2025	$	5,247
2026	9,762
2027	8,264
2028	6,579
2029	2,447
Thereafter	3,460
Total minimum lease payments	35,759
Less: imputed interest	(6,038)
Present value of future minimum lease payments	$	29,721

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

7. Accrued and Other Current Liabilities

Accrued and other current liabilities included the following:


	June 28, 2025		December 31, 2024
Accrued customer incentives	$	39,180	$	52,153
Accrued payroll and benefits	23,585		19,465
Accrued interest	20,852		12,674
Accrued income taxes	3,815		4,445
Accrued property and other taxes	6,845		6,265
Deferred revenue(a)	6,385		11,128
Other current liabilities(b)	46,256		64,655
Accrued and other current liabilities	$	146,918	$	170,785

(a)Included at December 31, 2024 was $3 million (CAD $5 million) associated with funds received in 2021 for CEWS. In the second quarter of 2025, the Company recognized this amount in “income from discontinued operations, net of taxes” in the condensed consolidated statements of operations.

(b)Included at June 28, 2025 and December 31, 2024 were $19 million and $17 million, respectively, of energy-related payables associated with Tartas facility operations.

8. Debt and Finance Leases

Debt and finance leases included the following:


	June 28, 2025		December 31, 2024
ABL Credit Facility due November 2029: $116 million net availability, bearing interest of 6.4% (4.4% adjusted SOFR plus 2.0% margin) at June 28, 2025	$	12,450	$	—
2029 Term Loan due October 2029: bearing interest of 11.3% (4.3% three-month Term SOFR plus 7.0% margin) at June 28, 2025	698,250		700,000
5.50% CAD-based term loan due April 2028	19,537		21,184
BioNova debt(a)	22,524		21,120
Other loans(b)	34,968		32,536
Short-term factoring facility	1,865		2,304
Finance lease obligations	693		921
Total principal payments due	790,287		778,065
Less: unamortized premium, discount and issuance costs	(44,593)		(48,242)
Total debt	745,694		729,823
Less: debt due within one year	(25,342)		(23,379)
Long-term debt	$	720,352	$	706,444

(a)Consists of green loans associated with the France bioethanol plant, part of the net assets contributed by the Company to its subsidiary, BioNova.

(b)Consist of loans for energy projects in France.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

As of June 28, 2025, there were no borrowings outstanding under the BioNova Term Loan.

Covenants and Debt Maturity

As of June 28, 2025, the Company was in compliance with all covenants under its debt agreements and the Company’s debt principal payments, excluding finance lease obligations, were due as follows:


Remainder of 2025	$	28,690
2026	22,053
2027	20,529
2028	18,841
2029	681,077
Thereafter	18,404
Total debt principal payments	$	789,594

9. Environmental Liabilities

The Company’s environmental liabilities balance changed as follows during the six months ended June 28, 2025:


Balance at December 31, 2024	$	170,215
Increase in liabilities	14,404
Payments	(3,161)
Foreign currency adjustments	423
Balance at June 28, 2025	$	181,881
Current environmental liabilities	$	9,764
Non-current environmental liabilities	$	172,117

Port Angeles, Washington

The Company operated a pulp mill at this site from 1930 until 1997. Since 2000, the Company has been evaluating remediation of the pulp mill site and adjacent marine areas (a portion of Port Angeles harbor) pursuant to an agreed order with the Washington DOE under the Washington MTCA. During this period, the Company has performed several voluntary interim soil cleanup actions. As the next step in collaboration with the Washington DOE, the parties are negotiating a consent order that will formalize approved remedial actions, which include more stringent cleanup standards and an expanded scope. Consequently, in the first quarter of 2025, the Company increased its estimated remediation liability and recorded an expense of $10 million. The associated cash expenditures are not expected to commence before 2028, with outflows anticipated over the subsequent three to five years.

Augusta, Georgia

The Company operated this site as a wood treatment plant from 1928 to 1988. This site operates under a 10-year RCRA hazardous waste facility permit managed by the Georgia EPD. The most recent permit was issued in 2015, and it must be renewed. In connection with the Company’s submittal of its permit renewal application, Georgia EPD notified the Company that a revised corrective action plan for the site would be required to capture results of a decade long extended investigation performed pursuant to the current permit. The revised corrective action plan is being drafted. It expands the remedial areas for the site and includes an additional off-site area, which were both identified through the investigative studies. To reflect the additional remedial activities in these expanded areas, in the first quarter of 2025, the Company increased the estimated remediation liability and recorded an expense of $2 million. The cash impact associated with this charge is expected in early 2027.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

Other

In addition to the estimated liabilities for the above remediation sites, the Company is subject to the risk of reasonably possible additional liabilities in excess of the established liabilities due to potential changes in circumstances and future events, including, without limitation, changes to current laws and regulations; changes in governmental agency personnel, direction, philosophy or enforcement policies; developments in remediation technologies; increases in the cost of remediation, operation, maintenance and monitoring of its environmental liability sites; changes in the volume, nature or extent of contamination to be remediated or monitoring to be undertaken; the outcome of negotiations with governmental agencies or non-governmental parties; and changes in accounting rules or interpretations. Based on information available as of June 28, 2025, the Company estimates this exposure could range up to approximately $77 million. However, no assurances can be given that this amount will not be exceeded given the factors described above. These potential additional costs are attributable to several sites and other applicable liabilities. This estimate excludes liabilities that would otherwise be considered reasonably possible but for the fact that they are not currently estimable, primarily due to the factors discussed above.

Subject to the previous paragraph, the Company believes its estimates of liabilities are sufficient for probable costs expected to be incurred over the next 20 years with respect to its environmental liabilities. However, no assurance is given that these estimates will be sufficient for the reasons described above and additional liabilities could have a material adverse effect on the Company’s financial position, results of operations and cash flows.

10. Fair Value Measurements

Liabilities Measured at Fair Value on a Recurring Basis

Redeemable Noncontrolling Interest - Put Option

In November 2024, BioNova issued 111,111 preferred shares to SWEN in return for a redeemable noncontrolling interest of approximately 14 percent. The preferred shares contain an embedded put option that was determined should be bifurcated and recognized separately at fair value, with subsequent changes in fair value recorded in earnings.

SWEN’s put option was initially measured at a fair value of $4 million and will be remeasured at the end of each reporting period. The fair value of the put option is estimated using a Monte Carlo simulation model, which is a Level 3 measurement, with changes in fair value recorded in “other income, net” in the condensed consolidated statements of operations. The SWEN put option’s liability balance and activity during the three and six months ended June 28, 2025 were as follows:


	Financial Statement Line Item	Three Months Ended June 28, 2025		Six Months Ended June 28, 2025
Balance at December 31, 2024	Other liabilities			$	4,196
Fair value measurement adjustment	Other income, net	$	558	1,052
Foreign currency translation adjustment	Foreign currency translation adjustment	$	385	550
Balance at June 28, 2025	Other liabilities			$	5,798

There is inherent uncertainty of the fair value measurement of Level 3 securities due to the use of unobservable inputs, including timing and amount of expected cash flows. A material change in the unobservable inputs used may result in a higher or lower fair value measurement. Key inputs into the Monte Carlo simulation model used to determine the fair value of the SWEN put option at the fair value measurement date were as follows:


	June 28, 2025		December 31, 2024

Free cash flow to equity volatility(a)	46.0	%	52.0	%
Risk-free interest rate	Term structure of U.S. Treasury and Euro Government Bond securities		Term structure of U.S. Treasury and Euro Government Bond securities
Weighted average cost of capital	11.8	%	12.1	%

(a)Based on a peer group of companies in the same or a similar industry.

See Note 11—Redeemable Noncontrolling Interest for further information on the put option.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

Financial Instruments

The carrying amounts of the Company’s cash and cash equivalents, receivables and payables approximate fair value due to the short-term nature of those instruments. The carrying amount of borrowings outstanding under the ABL Credit Facility, 2029 Term Loan and short-term factoring facility approximate fair value due to their variable interest rates and no significant changes in the Company's credit risk.

The fair value of the Company’s fixed rate debt is estimated using quoted market prices for debt with similar terms and maturities, which are Level 2 inputs, and was as follows:


	June 28, 2025		December 31, 2024
Carrying amount of fixed rate debt(a)	$	77,270	$	75,142
Fair value of fixed rate debt	$	79,146	$	75,272

(a)Excludes finance lease obligations.

11. Redeemable Noncontrolling Interest

In November 2024, the Company and one of its subsidiaries entered into a shareholder agreement with SWEN, pursuant to which SWEN will fund up to €30 million in exchange for up to 222,222 preferred shares, representing an expected 20 percent total noncontrolling equity interest in BioNova. Of this commitment, €15 million was funded at the closing of the shareholder agreement in exchange for 111,111 preferred shares, which currently represents an equity interest in BioNova of approximately 14 percent. Subsequent funding is contingent on the achievement of certain project milestones.

The value of SWEN’s redeemable noncontrolling interest is reflected in temporary equity and is accreted to its estimated redemption value at each period end using the interest method. The redeemable noncontrolling interest balance and activity during the quarter and six months ended June 28, 2025 were as follows:


	Three Months Ended June 28, 2025		Six Months Ended June 28, 2025
Balance, beginning of period	$	11,337	$	10,503


Adjustment to redemption value	481		889
Net income attributable to redeemable noncontrolling interest	18		36
Comprehensive income adjustments:
Foreign currency translation adjustment on redemption value	919		1,327
Balance at June 28, 2025	$	12,755	$	12,755

Results attributable to RYAM, after attribution to the redeemable noncontrolling interest, were as follows:


	Three Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Income (loss) from continuing operations attributable to RYAM	$	(365,867)	$	8,173	$	(397,837)	$	6,603
Income from discontinued operations attributable to RYAM	2,670		3,217		2,670		3,217
Net income (loss) attributable to RYAM	$	(363,197)	$	11,390	$	(395,167)	$	9,820

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

12. Accumulated Other Comprehensive Loss


	Six Months Ended
	June 28, 2025		June 29, 2024
Unrecognized components of employee benefit plans, net of tax
Balance, beginning of period	$	(21,060)	$	(33,537)
Other comprehensive income before reclassifications	—		3,371
Income tax on other comprehensive income	—		(901)
Reclassifications to earnings(a)
Amortization of gain	(373)		(391)
Amortization of prior service cost	125		359
Income tax on reclassifications	50		10
Net comprehensive income (loss) on employee benefit plans, net of tax	(198)		2,448
Balance, end of period	(21,258)		(31,089)

Unrealized loss on derivative instruments, net of tax
Balance, beginning of period	(222)		(373)
Reclassifications to earnings - foreign currency exchange contracts(b)	70		92
Income tax on reclassifications	(9)		(12)
Comprehensive income on derivative instruments, net of tax	61		80
Balance, end of period	(161)		(293)

Foreign currency translation
Balance, beginning of period	(24,387)		(12,007)
Foreign currency translation adjustment, net of tax(c)	24,389		(6,488)
Balance, end of period	2		(18,495)

Accumulated other comprehensive loss, end of period	$	(21,417)	$	(49,877)

(a)The AOCI components for defined benefit pension and post-retirement plans are included in the computation of net periodic benefit cost. See Note 15—Employee Benefit Plans for further information.

(b)Reclassifications of foreign currency exchange contracts are recorded in “cost of sales,” “other operating income (expense), net” or “other income (expense), net,” as appropriate.

(c)Foreign currency translation is net of tax effects of $0 for all periods presented, as the French operations are taxed on the foreign functional currency, not the translated reporting currency.

13. Earnings Per Common Share

Basic earnings per share is calculated by dividing net income available for common stockholders by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share is calculated by dividing net income available for common stockholders by the weighted average number of shares of common stock outstanding, adjusted for the potentially dilutive effect of outstanding performance-based stock and restricted stock.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

The following table provides the inputs to the calculations of basic and diluted earnings per common share (share amounts not in thousands):


	Three Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Income (loss) from continuing operations	$	(365,849)	$	8,173	$	(397,801)	$	6,603
Income from continuing operations attributable to redeemable noncontrolling interest	18		—		36		—
Income (loss) from continuing operations attributable to RYAM	(365,867)		8,173		(397,837)		6,603
Redeemable noncontrolling interest adjustment to redemption value	(481)		—		(889)		—
Income (loss) from continuing operations attributable to RYAM common stockholders	(366,348)		8,173		(398,726)		6,603
Income from discontinued operations, net of tax attributable to RYAM	2,670		3,217		2,670		3,217
Net income (loss) attributable to RYAM common stockholders	$	(363,678)	$	11,390	$	(396,056)	$	9,820

Weighted average shares used in determining basic earnings per common share	66,875,897		65,716,362		66,551,962		65,582,651
Dilutive effect of:
Stock options	—		—		—		3
Performance and restricted stock	—		3,073,949		—		2,423,674
Weighted average shares used in determining diluted earnings per common share	66,875,897		68,790,311		66,551,962		68,006,328

Anti-dilutive instruments excluded from the computation of diluted earnings per share included (not in thousands):


	Three Months Ended		Six Months Ended
	June 28, 2025	June 29, 2024	June 28, 2025	June 29, 2024
Stock options	—	—	—	1,497
Performance and restricted stock	2,760,125	421	2,760,125	6,376
Total anti-dilutive instruments	2,760,125	421	2,760,125	7,873

14. Incentive Stock Plans

Incentive stock plan compensation expense was as follows:


	Three Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Incentive stock plan compensation expense(a)	$	717	$	2,320	$	2,878	$	4,411

(a)Included equity award expense of $1 million and $2 million during the quarters ended June 28, 2025 and June 29, 2024, respectively, and $3 million during each of the six months ended June 28, 2025 and June 29, 2024.

The Company made new grants of restricted stock units, performance-based stock units and performance-based cash awards during the first and second quarters of 2025. The 2025 restricted stock unit awards cliff vest after three years, except for director awards, which vest after one year. The 2025 performance-based awards cliff vest after three years and are based equally on TSR relative to peers and three-year cumulative adjusted EBITDA. Participants can earn between 0 percent and 200 percent of the target award for each of the TSR and adjusted EBITDA metrics. Performance below the threshold for either metric would result in zero payout for that metric. The performance-based cash award is paid in cash and is classified as a liability and remeasured to fair value at the end of each reporting period until settlement.

In March 2025, the performance-based awards granted in 2022 were settled with an issuance of 654,995 shares of common stock for the stock unit awards, including incremental shares of 165,061, and cash of $2 million for the cash awards.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

The following table summarizes the 2025 activity of the Company’s incentive stock awards (not in thousands):


	Restricted Stock Units		Performance-Based Stock Units
		Awards	Weighted Average Grant Date Fair Value		Awards	Weighted Average Grant Date Fair Value
Outstanding at December 31, 2024		1,766,219	$	5.11	1,575,297	$	5.93
Granted		517,055	$	7.52	692,155	$	9.55
Forfeited		(60,538)	$	4.25	(279,125)	$	3.14
Exercised or settled		(795,943)	$	5.08	(654,995)	$	7.17

Outstanding at June 28, 2025		1,426,793	$	6.04	1,333,332	$	7.78

15. Employee Benefit Plans

Defined Benefit Plans

The Company has defined benefit pension and other long-term and postretirement benefit plans covering certain union and non-union employees, primarily in the U.S. and Canada. The defined benefit pension plans are closed to new participants. The liabilities for these plans are calculated using actuarial estimates and management assumptions. These estimates are based on historical information and certain assumptions about future events.

During the quarter and six months ended June 29, 2024, the Company recorded a $1 million loss on pension curtailment charges associated with early retirements driven by the indefinite suspension of operations at the Temiscaming High Purity Cellulose plant. The loss on curtailment was recognized in “indefinite suspension charges” in the Company’s condensed consolidated statements of operations. Additionally, the Company decreased its pension liability by $3 million. See Note 2—Indefinite Suspension of Operations for further information.

The following tables present the components of net periodic benefit costs of these plans:


	Pension				Postretirement
	Three Months Ended				Three Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Service cost	$	1,188	$	1,527	$	111	$	138
Interest cost	6,911		6,889		239		247
Expected return on plan assets	(7,701)		(8,052)		—		—
Amortization of prior service cost (credit)	108		203		(43)		(25)
Amortization of (gain) loss	57		(11)		(244)		(184)

Curtailment	—		736		—		—
Net periodic benefit cost	$	563	$	1,292	$	63	$	176

	Pension				Postretirement
	Six Months Ended				Six Months Ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Service cost	$	2,358	$	3,064	$	221	$	276
Interest cost	13,740		13,812		476		495
Expected return on plan assets	(15,273)		(16,128)		—		—
Amortization of prior service cost (credit)	211		408		(86)		(49)
Amortization of (gain) loss	114		(22)		(487)		(369)

Curtailment	—		736		—		—
Net periodic benefit cost	$	1,150	$	1,870	$	124	$	353

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

Service cost is included in “cost of sales” or “selling, general and administrative expense” in the condensed consolidated statements of operations, as appropriate. Interest cost, expected return on plan assets, amortization of prior service cost (credit) and amortization of gain (loss) are included in “components of pension and OPEB, excluding service costs” in the condensed consolidated statements of operations.

16. Income Taxes

Effective Tax Rate

The Company’s effective tax rates were as follows:


	Three Months Ended						Six Months Ended
	June 28, 2025			June 29, 2024			June 28, 2025			June 29, 2024
Income (loss) from continuing operations before income tax	$	(26,160)		$	7,775		$	(63,332)		$	6,185
Effective tax rate	(1296.6)		%	(10.9)		%	(526.8)		%	(21.4)		%

The effective tax rates for the quarter and six months ended June 28, 2025 differed from the federal statutory rate of 21 percent primarily due to the full write-off of the Company’s Canadian DTAs. See Deferred Taxes below. Also driving the differences were different statutory tax rates in foreign jurisdictions, valuation allowances on nondeductible U.S. interest expense, U.S. tax credits and nondeductible executive compensation.

The effective tax rates for the quarter and six months ended June 29, 2024 differed from the federal statutory rate of 21 percent primarily due to the release of certain tax reserves, return-to-accrual adjustments, excess deficit on vested stock compensation and changes in the valuation allowance on disallowed interest deductions.

Deferred Taxes

The Company assesses the realizability of its DTAs to determine if a valuation allowance is required based on the consideration of all available evidence using a “more-likely-than-not” standard, with significant weight being given to evidence that can be objectively verified. Since the Company operates in multiple jurisdictions, it assesses the need for a valuation allowance on a jurisdiction-by-jurisdiction basis, considering local earnings and effects of local tax law.

As of December 31, 2024, the Company evaluated realizability of its significant Canadian DTAs using the framework of ASC 740 and concluded that a valuation allowance was not required. The Company acknowledged, however, that difficult market conditions could result in the materialization of a cumulative three-year loss, which would constitute significant negative evidence under ASC 740 and likely necessitate a valuation allowance.

As of June 28, 2025, the Company now expects to incur a cumulative adjusted pre-tax loss in Canada over the three most recent fiscal years ending in 2025. As a result of the significant weight of this negative evidence under ASC 740, the Company believes it is more likely than not that its Canadian DTAs will not be fully realizable and have therefore provided for a full valuation allowance against these assets. This results in a current quarter tax expense to write off the previously recognized net DTA of $337 million and current quarter Canadian pretax losses providing zero tax benefit on the financial statements. Barring positive evidence that changes this conclusion, future Canadian earnings will not result in tax expense or benefits on the Company’s financial statements. The valuation allowance does not impact the Company’s legal right to use the deferred tax assets against cash taxes and future recognition will continue to be evaluated as market conditions evolve.

As of June 28, 2025 and December 31, 2024, the Company’s net DTA included $13 million and $15 million, respectively, of disallowed U.S. interest deductions that the Company does not believe will be realized. The decrease in this asset was a result of a $2 million tax expense recognized in the current year. In strict compliance with the American Institute of Certified Public Accountants’ Technical Questions and Answers 3300.01-02, which asserts that certain material evidence regarding the realizability of disallowed U.S. interest deductions should be ignored when assessing the need for a valuation allowance, the Company has not recognized a valuation allowance on this portion of the net DTA generated from disallowed interest.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

17. Segments

As discussed in Note 1—Nature of Operations and Basis of Presentation, beginning in the first quarter of 2025, the Company reorganized its segment structure and now operates in five operating segments: Cellulose Specialties, Cellulose Commodities, Biomaterials, Paperboard and High-Yield Pulp. Corporate consists primarily of senior management, accounting, information systems, human resources, treasury, tax and legal administrative functions that provide support services to the operating business units. Prior period segment results have been recast to align with this new segment reporting structure.

The Company uses operating income (loss) as a measure of profitability to evaluate segment performance. Intersegment sales consist primarily of High-Yield Pulp sales to Paperboard, which are eliminated in consolidation. Additionally, there are intersegment sales of chemicals, sugars and energy from the cellulose plants to Biomaterials, also eliminated in consolidation. Intersegment sales prices are at rates that approximate market for the respective operating area.

Net sales, significant operating expenses, operating income (loss) and other financial information by segment were as follows:


	Three Months Ended June 28, 2025
	Cellulose Specialties		Biomaterials		Cellulose Commodities		Paperboard		High-Yield Pulp		Corporate(a) and Eliminations		Total
Net sales	$	207,682	$	6,531	$	59,443	$	46,451	$	28,858	$	(8,917)	$	340,048
Cost of sales
Key input costs (wood, chemicals, energy)	81,770		1,362		27,482		22,695		17,134		(8,685)		141,758
Freight	9,365		527		4,407		4,617		5,957		—		24,873
Depreciation and amortization	16,705		579		7,438		2,904		517		—		28,143
Fixed and other general costs(b)	67,121		1,708		27,751		14,122		11,410		(479)		121,633
Total cost of sales	174,961		4,176		67,078		44,338		35,018		(9,164)		316,407
Selling, general and administrative expense	3,414		1,308		1,287		2,637		717		8,602		17,965

Indefinite suspension charges	—		—		229		—		—		—		229
Other operating expense, net(c)	761		57		562		—		9		5,397		6,786
Operating income (loss)	$	28,546	$	990	$	(9,713)	$	(524)	$	(6,886)	$	(13,752)	$	(1,339)


Total depreciation and amortization	$	16,798	$	754	$	7,178	$	5,382	$	546	$	529	$	31,187


	Three Months Ended June 29, 2024
	Cellulose Specialties		Biomaterials		Cellulose Commodities		Paperboard		High-Yield Pulp		Corporate(a) and Eliminations		Total
Net sales	$	240,642	$	7,790	$	85,458	$	60,299	$	32,833	$	(7,977)	$	419,045
Cost of sales
Key input costs (wood, chemicals, energy)	90,517		1,587		49,135		31,025		17,708		(8,525)		181,447
Freight	11,087		858		7,410		5,176		5,260		—		29,791
Depreciation and amortization	17,966		657		10,807		1,494		558		—		31,482
Fixed and other general costs(b)	69,571		2,968		34,787		10,276		9,310		1,104		128,016
Total cost of sales	189,141		6,070		102,139		47,971		32,836		(7,421)		370,736
Selling, general and administrative expense	2,928		289		1,893		2,461		767		13,471		21,809

Indefinite suspension charges	—		—		6,626		—		—		—		6,626
Other operating (income) expense, net(c)	(893)		(4)		(4,461)		(2,333)		(1,583)		951		(8,323)
Operating income (loss)	$	49,466	$	1,435	$	(20,739)	$	12,200	$	813	$	(14,978)	$	28,197


Total depreciation and amortization	$	18,578	$	653	$	9,796	$	3,206	$	563	$	715	$	33,511

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)


	Six Months Ended June 28, 2025
	Cellulose Specialties		Biomaterials		Cellulose Commodities		Paperboard		High-Yield Pulp		Corporate(a) and Eliminations		Total
Net sales	$	408,790	$	13,452	$	134,498	$	95,644	$	60,347	$	(16,716)	$	696,015
Cost of sales
Key input costs (wood, chemicals, energy)	161,206		2,587		66,374		49,377		36,274		(16,527)		299,291
Freight	18,653		1,055		10,737		9,465		12,213		—		52,123
Depreciation and amortization	31,883		1,099		17,136		6,132		1,076		—		57,326
Fixed and other general costs(b)	128,792		3,239		57,462		26,859		23,476		(248)		239,580
Total cost of sales	340,534		7,980		151,709		91,833		73,039		(16,775)		648,320
Selling, general and administrative expense	7,432		2,667		3,671		5,514		1,330		20,610		41,224

Indefinite suspension charges	—		—		634		—		—		—		634
Other operating expense, net(c)	1,002		71		922		471		9		19,794		22,269
Operating income (loss)	$	59,822	$	2,734	$	(22,438)	$	(2,174)	$	(14,031)	$	(40,345)	$	(16,432)


Total depreciation and amortization	$	31,650	$	1,235	$	16,928	$	10,634	$	1,121	$	870	$	62,438


	Six Months Ended June 29, 2024
	Cellulose Specialties		Biomaterials		Cellulose Commodities		Paperboard		High-Yield Pulp		Corporate(a) and Eliminations		Total
Net sales	$	445,994	$	14,577	$	180,731	$	113,259	$	67,159	$	(15,019)	$	806,701
Cost of sales
Key input costs (wood, chemicals, energy)	171,034		2,707		99,667		58,024		36,676		(15,452)		352,656
Freight	20,895		1,735		14,823		10,023		11,004		—		58,480
Depreciation and amortization	33,761		757		22,285		2,897		1,147		—		60,847
Fixed and other general costs(b)	128,590		5,668		76,834		19,660		18,198		698		249,648
Total cost of sales	354,280		10,867		213,609		90,604		67,025		(14,754)		721,631
Selling, general and administrative expense	5,588		570		4,177		4,879		1,575		26,095		42,884

Indefinite suspension charges	—		—		6,626		—		—		—		6,626
Other operating expense, net(c)	(842)		(25)		(4,451)		(2,333)		(1,583)		(478)		(9,712)
Operating income (loss)	$	86,968	$	3,165	$	(39,230)	$	20,109	$	142	$	(25,882)	$	45,272


Total depreciation and amortization	$	35,807	$	748	$	21,520	$	6,436	$	1,119	$	1,164	$	66,794

(a)Includes ERP and certain lease expense shared across operating segments.

(b)Includes salaries, wages and benefits, maintenance costs and other costs of sales.

(c)Primarily includes foreign exchange gain (loss), environmental remediation expense, gain (loss) on disposal of property, plant and equipment and income (loss) from equity method investments.

Due to their integrated nature, certain operating and production assets are jointly utilized across the Cellulose Specialties and Cellulose Commodities segments. These assets are essential for the production processes of both types of products and are not directly attributable to either segment. As such, direct allocation to a specific segment is not feasible or prudent and they are considered shared assets. The Company allocates related fixed, maintenance and other costs based on a rational and consistent approach that reflects the segments’ contribution, usage and economic benefit derived from the shared assets in the production process, which varies from period to period between specialties and commodities products.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

Identifiable assets by segment were as follows:


	June 28, 2025		December 31, 2024
Cellulose Specialties	$	176,801	$	214,659
Biomaterials	89,373		78,006
Cellulose Commodities	170,177		187,996
Paperboard	96,969		93,600
High-Yield Pulp	46,505		49,798
Shared/Corporate(a)	1,175,143		1,505,597
Total assets	$	1,754,968	$	2,129,657

(a)At June 28, 2025 and December 31, 2024, included $1.1 billion and $1.0 billion, respectively, of assets shared by Cellulose Specialties and Cellulose Commodities. Corporate includes ERP and certain other operating and lease assets shared across segments.

Capital additions by segment were as follows:


	Six Months Ended
	June 28, 2025		June 29, 2024
Cellulose Specialties	$	—	$	—
Biomaterials	1,429		7,590
Cellulose Commodities	1,537		6,904
Paperboard	1,502		1,655
High-Yield Pulp	1,895		962
Shared/Corporate(a)	55,858		41,488
Total capital additions(b)	$	62,221	$	58,599

(a)Includes $54 million and $36 million of asset additions during the six months ended June 28, 2025 and June 29, 2024, respectively, that are shared by Cellulose Specialties and Cellulose Commodities. Corporate includes capital additions for ERP and certain other operational assets shared across segments.

(b)Amounts exclude the impact of changes in capital assets purchased on account and government grants.

18. Commitments and Contingencies

Commitments

The Company had no material changes outside the ordinary course of business to the purchase obligations presented in its 2024 Form 10-K during the six months ended June 28, 2025. The Company’s purchase obligations primarily consist of commitments for the purchase of natural gas, electricity and wood chips.

The Company leases certain buildings, machinery and equipment under various operating and finance leases. See Note 6—Leases for further information.

Litigation and Contingencies

The Company is engaged in various legal and regulatory actions and proceedings and has been named as a defendant in various lawsuits and claims arising in the ordinary course of business. While the Company has procured reasonable and customary insurance covering risks normally occurring in connection with its business, the Company has, in certain cases, retained some risk through the operation of self-insurance, primarily in the areas of workers’ compensation, property insurance, business interruption and general liability. These other lawsuits and claims, either individually or in the aggregate, are not expected to have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Guarantees and Other

The Company provides financial guarantees as required by creditors, insurance programs and various governmental agencies. As of June 28, 2025, the Company had net exposure of $28 million from various standby letters of credit, primarily for financial assurance relating to environmental remediation, credit support for natural gas and electricity purchases and guarantees related to foreign retirement plan obligations. These standby letters of credit represent a contingent liability; the Company would only be liable upon its default on the related payment obligations. The standby letters of credit have various expiration dates and are expected to be renewed as required.

Table of Contents

Rayonier Advanced Materials Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

(in thousands unless otherwise stated)

The Company had surety bonds of $92 million as of June 28, 2025, primarily to comply with financial assurance requirements relating to environmental remediation and post-closure care, to provide collateral for the Company’s workers’ compensation program and to guarantee taxes and duties for products shipped internationally. These surety bonds expire at various dates and are expected to be renewed annually as required.

LTF is a venture in which the Company owns 45 percent, and its partner, Borregaard ASA, owns 55 percent. The Company is a guarantor of LTF’s financing agreements and, in the event of default, expects it would only be liable for its proportional share of any repayment under the agreements. The Company’s proportion of the LTF financing agreement guarantee was $26 million at June 28, 2025.

The Company has not recorded any liabilities for these financial guarantees in its condensed consolidated balance sheets because the Company has recorded the underlying liability associated with the guarantee, the guarantee is dependent on the Company’s own performance and, therefore, is not subject to the measurement requirements or the Company has calculated the estimated fair value of the guarantee and determined it to be immaterial based upon the current facts and circumstances that would trigger a payment obligation.

It is not possible to determine the maximum potential amount of liability under these potential obligations due to the unique set of facts and circumstances likely to be involved with each provision.

On June 30, 2025, collective bargaining agreements covering approximately 640 unionized employees at the Jesup plant expired. The employees continued to work under the terms of the expired contracts during negotiations and on July 18, 2025, new contracts, effective through June 30, 2029, were ratified. All of the Company’s other collective bargaining agreements were current as of June 28, 2025.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following analysis of our financial condition and results of operations should be read in conjunction with our Financial Statements and the notes thereto included in this Quarterly Report on Form 10-Q and with our 2024 Form 10-K and information contained in subsequent Forms 8-K and other reports filed with the SEC.

Forward-Looking Statements

Certain statements in this Quarterly Report on Form 10-Q regarding anticipated financial, business, legal or other outcomes, including business and market conditions, outlook and other similar statements relating to future events, developments or financial or operational performance or results, are “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward-looking statements are identified by the use of words such as “may,” “will,” “should,” “could,” “expect,” “estimate,” “target,” “believe,” “intend,” “plan,” “forecast,” “anticipate,” “project,” “guidance” and other similar language. However, the absence of these or similar words or expressions does not mean that a statement is not forward-looking.

Forward-looking statements are not guarantees of future performance or events and undue reliance should not be placed on these statements. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that these expectations will be attained, and it is possible that actual results may differ materially from those indicated by these forward-looking statements due to various risks and uncertainties. The risk factors contained in Item 1A—Risk Factors of our 2024 Form 10-K, among others, could cause actual results or events to differ materially from our historical experience and those expressed in forward-looking statements made in this report.

Forward-looking statements are only as of the date of the filing of this Quarterly Report on Form 10-Q, and we undertake no duty to update forward-looking statements except as required by law. You are advised to review any disclosures that we have made or may make in our filings and other submissions to the SEC, including those on Forms 10-K, 10-Q, 8-K and other reports.

Business Overview

We are a global leader in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. Building upon nearly 100 years of experience in cellulose chemistry, we provide some of the highest quality high-purity cellulose pulp products that make up the essential building blocks for our customers’ products while providing exceptional service and value. Our specialized assets also produce bioelectricity, biomaterials, including biofuels, lignin and tall oil soap, and commodity fluff, viscose and paper pulp.

Additionally, we produce a unique, lightweight multi-ply paperboard product and a bulky, high-yield pulp product. Our paperboard is used for production in the commercial printing, lottery ticket and high-end packaging sectors. Our high-yield pulp is used by paperboard producers as well as in traditional printing, writing and specialty paper manufacturing.

New Segment Structure

In the first quarter of 2025, we reorganized our High Purity Cellulose operating segment as a result of changes in our internal operating model, significant developments in our Biomaterials strategy and the successful launch of an enterprise reporting system that significantly enhances our financial reporting and costing capabilities. Specifically, we determined, in light of these new developments and capabilities, that the performance and outlook of the High Purity Cellulose business will be better managed as three separate businesses: Cellulose Specialties, Cellulose Commodities and a new Biomaterials business. No changes were made to the composition of the Paperboard and High-Yield Pulp operating segments.

As a result of this reorganization, we now operate in five operating segments: Cellulose Specialties, Biomaterials, Cellulose Commodities, Paperboard and High-Yield Pulp. Prior period segment results have been recast to align with this new segment reporting structure.

Business Outlook

Our business has been significantly impacted by several extraordinary and primarily non-recurring challenges during the first half of the year, including global trade disruptions, tariff-driven market volatility, operational challenges, softer demand in Paperboard and High-Yield Pulp, a non-cash environmental charge and foreign exchange headwinds.

Table of Contents

While these near-term pressures weighed on second quarter results, they are largely considered to have peaked in the period. Since May, order trends in Cellulose Specialties have improved month over month and operational performance across our cellulose facilities has remained broadly stable. With signs of normalization emerging, RYAM is positioned to rebuild momentum in the second half of the year.

Looking ahead, we expect to meaningfully grow EBITDA over the two years following 2025, supported by focused efforts to increase Cellulose Specialties sales volume from the expected market demand growth, expand Cellulose Specialties margins by increasing prices and investing in high return cost reduction projects and accelerate high-return investments in Biomaterials. These actions are core to RYAM’s long-term strategy.

We remain committed to disciplined capital allocation. As previously disclosed, we began a process to explore the sale of our Paperboard and High-Yield Pulp businesses; however, given current market conditions and trade-related uncertainty, the process is now effectively on hold.

The following segment outlooks reflect RYAM’s current performance expectations for our operating businesses for the remainder of 2025.

Cellulose Specialties

Average cellulose specialties sales prices in 2025 are expected to increase by a mid single-digit percentage compared to the prior year. Sales volumes are anticipated to decline by a high single-digit percentage, reflecting tariff impacts, accelerated destocking of acetate and the absence of 2024 bridge volumes following the indefinite suspension of production at the Temiscaming plant. Acetate demand remains soft due to tariff-driven impacts, accelerated customer destocking and weaker global cigarette market trends. Ethers volumes are anticipated to improve, while demand for other cellulose specialties grades remains strong, supported by tight global supply conditions. Raw material input and logistics costs are expected to increase moderately year-over-year. All cellulose plants are currently running at expected operating rates.

Biomaterials

We continue to evaluate investments in new green energy and renewable products to provide both increased end-market diversity and incremental profitability. We intend to proceed only with those projects that are expected to meet our investment hurdles: a minimum 30 percent return on equity and a less than two-year payback period for RYAM equity. In the fourth quarter of 2024, we secured green capital of €67 million, which allows us to advance the biomaterials strategy and further progress towards our goal of generating over $70 million of EBITDA from RYAM’s Biomaterials business, inclusive of the projects summarized below:

•Our bioethanol facility in France is operational since the first quarter of 2024.

•We re-started our lignosulfonate powder plant in France in the first quarter of 2025.

•We continue to pursue an investment in a bioethanol facility in Fernandina Beach, Florida, similar to our bioethanol facility in France. While the City of Fernandina Beach recently denied the site plan application for this project, we believe the City erred in making its determination and we are pursuing all available legal remedies. In expectation of a favorable outcome, we continue to advance engineering plans and explore potential commercial agreements.

•We are evaluating investments in crude tall oil facilities in Jesup, Georgia and Tartas and a prebiotics facility at the Jesup plant, and are currently working on permitting, engineering and commercial agreements for these new facilities. In July 2025, we received GRAS status for our prebiotics product with a letter of no objection from the U.S. Food and Drug Administration.

•We are a partner in AGE, a start-up entity that aims to utilize renewable forestry waste and other biomass generally discarded as waste to generate green electricity for the State of Georgia from a new facility to be constructed adjacent to our Jesup plant. Although the project remains in the development phase, AGE is actively evaluating the construction and financing requirements for the new facility.

•We recently signed Memoranda of Understanding with Verso Energy to explore eSAF opportunities at both our Jesup and Tartas facilities, and with GranBio to develop a pilot-scale SAF plant at the Jesup site.

We expect to make final investment decisions on several of these projects in 2025.

Table of Contents

Cellulose Commodities

Chinese retaliatory tariffs continue to disrupt global fluff market dynamics, creating a mismatch between supply and demand. As a result, RYAM’s production is being actively shifted toward non-fluff commodities until RYAM’s new dissolving wood pulp fluff product is fully qualified in China. While demand remains uncertain, we will continue to adjust production mix to mitigate the impact of direct tariffs and related second-order effects. Raw material input and logistics costs are expected to increase moderately.

Paperboard

Paperboard sales volumes are expected to remain soft due to continued economic uncertainty and weaker customer demand. Additionally, prices are expected to decline year-over-year, reflecting increased competitive activity from new U.S. competitor capacity. Input costs are projected to rise as a result of higher purchased pulp prices, increased allocation of Temiscaming custodial site costs and ongoing tariff mitigation efforts. In response to ongoing market weakness and a softer sales outlook, we are idling Paperboard production for two weeks during the third quarter as a proactive measure to align inventory levels with demand and preserve cash flow.

High-Yield Pulp

High-Yield Pulp sales prices and volumes are expected to decline in 2025, driven primarily by continued oversupply in the Chinese market. Input costs are also projected to rise due to a higher allocation of custodial site costs at the Temiscaming facility. Given the ongoing market weakness, we continue to take proactive steps to manage production and costs. In response to ongoing market weakness and a softer sales outlook, we are idling High-Yield Pulp production for three weeks during the third quarter to proactively manage inventory levels and preserve cash flow.

Corporate

Corporate costs for full year 2025 are expected to be higher compared to the prior year primarily due to the $12 million of non-cash environmental reserve charges recorded in the first quarter and potential continued foreign exchange headwinds from a weaker U.S. dollar. These impacts are expected to be partially offset by lower corporate spending in the second half of the year following the completion of our ERP implementation.

Table of Contents

Results of Operations


	Three Months Ended						Six Months Ended
(in millions, except percentages)	June 28, 2025			June 29, 2024			June 28, 2025			June 29, 2024
Net sales	$	340		$	419		$	696		$	807
Cost of sales	(316)			(371)			(648)			(722)
Gross margin	24			48			48			85
Selling, general and administrative expense	(18)			(21)			(41)			(42)
Foreign exchange gain (loss)	(4)			—			(5)			3

Indefinite suspension charges	(1)			(7)			(1)			(7)
Other operating (expense), net	(2)			8			(17)			6
Operating income (loss)	(1)			28			(16)			45
Interest expense	(23)			(21)			(47)			(42)


Other income (expense), net	(2)			1			—			3
Income (loss) from continuing operations before income tax	(26)			8			(63)			6
Income tax (expense) benefit	(339)			1			(334)			2
Equity in loss of equity method investment	(1)			(1)			(1)			(1)
Income (loss) from continuing operations	(366)			8			(398)			7
Income from discontinued operations, net of tax	3			3			3			3
Net income (loss)	(363)			11			(395)			10
Net income attributable to redeemable noncontrolling interest	—			—			—			—
Net income (loss) attributable to RYAM	$	(363)		$	11		$	(395)		$	10

Gross margin %	7.1		%	11.5		%	6.9		%	10.5		%
Operating margin %	(0.3)		%	6.7		%	(2.3)		%	5.6		%
Effective tax rate	(1,296.6)		%	(10.9)		%	(526.8)		%	(21.4)		%

Net Sales


	Three Months Ended				Six Months Ended
(in millions)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Cellulose Specialties	$	208	$	241	$	409	$	446
Biomaterials	6		8		13		14
Cellulose Commodities	59		85		134		181
Paperboard	47		60		96		113
High-Yield Pulp	29		33		60		67
Eliminations	(9)		(8)		(16)		(14)
Net sales	$	340	$	419	$	696	$	807

Net sales for the quarter and six months ended June 28, 2025 decreased $79 million, or 19 percent, and $111 million, or 14 percent, respectively, compared to the same prior year periods driven by lower sales prices in Paperboard and High-Yield Pulp and lower sales volumes across all segments that were largely a response to imposed tariffs and a labor strike at the Tartas cellulose plant in the current quarter. Partially offsetting the decrease in sales volumes were higher sales prices in Cellulose Specialties and Cellulose Commodities.

See Operating Results by Segment below for further discussion.

Table of Contents

Operating Income (Loss)


	Three Months Ended				Six Months Ended
(in millions)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Cellulose Specialties	$	29	$	50	$	60	$	87
Biomaterials	1		1		3		3
Cellulose Commodities	(9)		(21)		(22)		(39)
Paperboard	—		12		(2)		20
High-Yield Pulp	(7)		1		(14)		—
Corporate	(15)		(15)		(41)		(26)
Operating income (loss)	$	(1)	$	28	$	(16)	$	45

Operating results for the quarter ended June 28, 2025 declined $29 million, or 104 percent, compared to the same prior year quarter driven primarily by the decrease in net sales, lower production due to operational challenges and the labor strike at the Tartas cellulose plant in the current quarter, unfavorable foreign exchange rates and the one-time prior year recognition of $10 million in CEWS benefit claims. Partially offsetting these decreases were lower indefinite suspension charges and lower variable compensation costs.

Operating results for the six months ended June 28, 2025 declined $61 million, or 136 percent, compared to the same prior year period driven primarily by the decrease in net sales, lower production due to operational challenges and the labor strike at the Tartas cellulose plant in the current period, current period non-cash environmental reserves charges of $12 million, unfavorable foreign exchange rates and the one-time prior year recognition of $10 million in CEWS benefit claims. Partially offsetting these decreases were lower indefinite suspension charges and lower variable compensation costs.

See Operating Results by Segment below for further discussion.

Non-Operating Income & Expense

Interest expense for the quarter and six months ended June 28, 2025 increased $2 million and $5 million, respectively, compared to the same prior year periods driven primarily by an increase in the average effective interest rate on debt, partially offset by a decrease in the average outstanding principal balance. Total debt decreased $32 million from June 29, 2024 to June 28, 2025.

Unfavorable foreign exchange rates during the quarter and six months ended June 28, 2025 compared to favorable rates in the same prior year periods resulted in net unfavorable impacts of $2 million and $3 million, respectively.

Income Taxes

The effective tax rates on the loss from continuing operations for the quarter and six months ended June 28, 2025 were not meaningful as a result of the valuation allowance placed on our Canadian DTAs. Also driving the differences between the effective tax rates and the federal statutory rate of 21 percent were different statutory tax rates in foreign jurisdictions, valuation allowances on nondeductible U.S. interest expense, U.S. tax credits and nondeductible executive compensation.

The effective tax rates on income from continuing operations for the quarter and six months ended June 29, 2024 were benefits of 11 percent and 21 percent, respectively. These rates differed from the federal statutory rate of 21 percent primarily due to the release of certain tax reserves, return-to-accrual adjustments, excess deficit on vested stock compensation and changes in the valuation allowance on disallowed interest deductions.

See Note 16—Income Taxes to our Financial Statements for further details of the Canadian DTA write-off.

Discontinued Operations

During the quarter and six months ended June 28, 2025, we recorded pre-tax income from discontinued operations of $4 million related to the remaining CEWS benefit claims deferred since 2021.

During the quarter and six months ended June 29, 2024, we recorded pre-tax income from discontinued operations of $5 million related to CEWS benefit claims deferred since 2021 and a pre-tax loss of $1 million on the sale of our softwood lumber duty refund rights.

Table of Contents

See Note 3—Discontinued Operations to our Financial Statements for further details.

Operating Results by Segment

Following the indefinite suspension of Temiscaming cellulose operations in the third quarter of 2024, certain infrastructure assets of the site’s cellulose plant continue to run in support of the ongoing energy needs of the Paperboard and High-Yield Pulp operations. As such, beginning in the fourth quarter of 2024, the net impact of the custodial site costs being incurred and the sales of any electricity generated by the running of the cellulose plant assets are reflected within the operating results of the Paperboard and High-Yield Pulp businesses.

Cellulose Specialties


	Three Months Ended				Six Months Ended
(in millions, unless otherwise stated)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Net sales	$	208	$	241	$	409	$	446
Operating income	$	29	$	50	$	60	$	87
Average sales prices ($ per MT)	$	1,807	$	1,750	$	1,783	$	1,733
Sales volumes (thousands of MTs)	111		130		221		244

Net Sales - Three Months Ended


	Three Months Ended June 29, 2024		Changes Attributable to:				Three Months Ended June 28, 2025
(in millions)	Three Months Ended June 29, 2024		Price		Volume/Mix/Other		Three Months Ended June 28, 2025
Net sales	$	241	$	6	$	(39)	$	208

Net sales of our Cellulose Specialties segment for the quarter ended June 28, 2025 decreased $33 million, or 14 percent, compared to the same prior year quarter driven by a 15 percent decrease in sales volumes that was in line with expectations and due primarily to a pause in customer orders driven by uncertainty surrounding imposed tariffs, strong sales in the prior year quarter ahead of the indefinite suspension of Temiscaming cellulose operations in July 2024 and the impact of the labor strike at the Tartas cellulose plant in the current quarter. Partially offsetting the sales volume decrease was a 3 percent increase in sales prices.

Net Sales - Six Months Ended


	Six Months Ended June 29, 2024		Changes Attributable to:				Six Months Ended June 28, 2025
(in millions)	Six Months Ended June 29, 2024		Price		Volume/Mix/Other		Six Months Ended June 28, 2025
Net sales	$	446	$	11	$	(48)	$	409

Net sales of our Cellulose Specialties segment for the six months ended June 28, 2025 decreased $37 million, or 8 percent, compared to the same prior year period driven by a 9 percent decrease in sales volumes due primarily to a pause in customer orders driven by uncertainty surrounding imposed tariffs, strong sales in the prior year period ahead of the indefinite suspension of Temiscaming cellulose operations and the impact of the labor strike at the Tartas cellulose plant in the current period. Partially offsetting the sales volume decrease was a 3 percent increase in sales prices.

Operating Income - Three Months Ended


	Three Months Ended June 29, 2024			Gross Margin Changes Attributable to:												Three Months Ended June 28, 2025
(in millions, except percentages)				Sales Price			Sales Volume/Mix/Other(a)			Cost			SG&A and other
Operating income	$	50		$	6		$	(21)		$	(4)		$	(2)		$	29
Operating margin %	20.7		%	1.9		%	(5.8)		%	(1.9)		%	(1.0)		%	13.9		%

(a)Computed based on contribution margin.

Table of Contents

Operating income of our Cellulose Specialties segment for the quarter ended June 28, 2025 decreased $21 million, or 42 percent, compared to the same prior year quarter driven by the lower sales volumes, higher key input costs, lower production due to operational challenges and the labor strike at the Tartas cellulose plant, and the one-time prior year recognition of $3 million in CEWS benefit claims.

Operating Income - Six Months Ended


	Six Months Ended June 29, 2024			Gross Margin Changes Attributable to:												Six Months Ended June 28, 2025
(in millions, except percentages)				Sales Price			Sales Volume/Mix/Other(a)			Cost			SG&A and other
Operating income	$	87		$	11		$	(27)		$	(7)		$	(4)		$	60
Operating margin %	19.5		%	1.9		%	(4.1)		%	(1.7)		%	(0.9)		%	14.7		%

(a)Computed based on contribution margin.

Operating income of our Cellulose Specialties segment for the six months ended June 28, 2025 decreased $27 million, or 31 percent, compared to the same prior year period driven by the lower sales volumes, higher key input costs, lower production due to operational challenges and the labor strike at the Tartas cellulose plant, and the one-time prior year recognition of $3 million in CEWS benefit claims.

Biomaterials


	Three Months Ended				Six Months Ended
(in millions)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Net sales	$	6	$	8	$	13	$	14
Operating income	$	1	$	1	$	3	$	3

Net Sales - Three Months Ended

Net sales of our Biomaterials segment for the quarter ended June 28, 2025 decreased $2 million, or 25 percent, compared to the same prior year quarter driven by lower production due to operational challenges and the impact of the labor strike at the Tartas cellulose plant in the current quarter, which limited raw material supply due to the bioethanol facility’s reliance on the Tartas cellulose plant for feedstock.

Net Sales - Six Months Ended

Net sales of our Biomaterials segment for the six months ended June 28, 2025 decreased $1 million, or 7 percent, compared to the same prior year period driven by lower production due to operational challenges and the impact of the labor strike at the Tartas cellulose plant in the current period, which limited raw material supply due to the bioethanol facility’s reliance on the Tartas cellulose plant for feedstock.

Operating Income - Three Months Ended

Operating income of our Biomaterials segment for the quarter ended June 28, 2025 was flat compared to the same prior year quarter as higher shared and ancillary service costs under the business’s newly established cost structure were offset by lower production costs as a result of the current quarter operational challenges and labor strike at the Tartas cellulose plant that reduced feedstock availability.

Operating Income - Six Months Ended

Operating income of our Biomaterials segment for the six months ended June 28, 2025 was flat compared to the same prior year period as higher shared and ancillary service costs under the business’s newly established cost structure were offset by lower production costs as a result of the current period operational challenges and labor strike at the Tartas cellulose plant that reduced feedstock availability.

Table of Contents

Cellulose Commodities


	Three Months Ended				Six Months Ended
(in millions, unless otherwise stated)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Net sales	$	59	$	85	$	134	$	181
Operating loss	$	(9)	$	(21)	$	(22)	$	(39)
Average sales prices ($ per MT)	$	911	$	849	$	883	$	850
Sales volumes (thousands of MTs)	64		96		149		201

Net Sales - Three Months Ended


	Three Months Ended June 29, 2024		Changes Attributable to:				Three Months Ended June 28, 2025
(in millions)	Three Months Ended June 29, 2024		Price		Volume/Mix/Other		Three Months Ended June 28, 2025
Net sales	$	85	$	3	$	(29)	$	59

Net sales of our Cellulose Commodities segment for the quarter ended June 28, 2025 decreased $26 million, or 31 percent, compared to the same prior year quarter driven by a 33 percent decrease in sales volumes due primarily to lower non-fluff commodity sales and the impact of the labor strike at the Tartas cellulose plant, partially offset by a 7 percent increase in sales prices driven by market supply dynamics for fluff.

Net Sales - Six Months Ended


	Six Months Ended June 29, 2024		Changes Attributable to:				Six Months Ended June 28, 2025
(in millions)	Six Months Ended June 29, 2024		Price		Volume/Mix/Other		Six Months Ended June 28, 2025
Net sales	$	181	$	3	$	(50)	$	134

Net sales of our Cellulose Commodities segment for the six months ended June 28, 2025 decreased $47 million, or 26 percent, compared to the same prior year period driven by a 26 percent decrease in sales volumes due primarily to lower non-fluff commodity sales and the impact of the labor strike at the Tartas cellulose plant, partially offset by a 4 percent increase in sales prices driven by market supply dynamics for fluff.

Operating Loss - Three Months Ended


	Three Months Ended June 29, 2024			Gross Margin Changes Attributable to:												Three Months Ended June 28, 2025
(in millions, except percentages)				Sales Price			Sales Volume/Mix/Other(a)			Cost			SG&A and other
Operating loss	$	(21)		$	3		$	(19)		$	26		$	2		$	(9)
Operating margin %	(24.7)		%	4.3		%	(42.3)		%	44.1		%	3.3		%	(15.3)		%

(a)Computed based on contribution margin.

Operating loss of our Cellulose Commodities segment for the quarter ended June 28, 2025 improved $12 million, or 57 percent, compared to the same prior year quarter driven by lower non-fluff commodity losses, lower indefinite suspension charges and lower key input costs, partially offset by lower production due to operational challenges and the labor strike at the Tartas cellulose plant, and the one-time prior year recognition of $2 million in CEWS benefit claims.

Operating Loss - Six Months Ended


	Six Months Ended June 29, 2024			Gross Margin Changes Attributable to:												Six Months Ended June 28, 2025
(in millions, except percentages)				Sales Price			Sales Volume/Mix/Other(a)			Cost			SG&A and other
Operating loss	$	(39)		$	3		$	(32)		$	45		$	1		$	(22)
Operating margin %	(21.5)		%	2.0		%	(31.2)		%	33.6		%	0.7		%	(16.4)		%

(a)Computed based on contribution margin.

Table of Contents

Operating loss of our Cellulose Commodities segment for the six months ended June 28, 2025 improved $17 million, or 44 percent, compared to the same prior year period driven by lower non-fluff commodity losses, lower indefinite suspension charges and lower key input costs, partially offset by lower production due to operational challenges and the labor strike at the Tartas cellulose plant, and the one-time prior year recognition of $2 million in CEWS benefit claims.

Paperboard


	Three Months Ended				Six Months Ended
(in millions, unless otherwise stated)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Net sales	$	47	$	60	$	96	$	113
Operating income (loss)	$	—	$	12	$	(2)	$	20
Average sales prices ($ per MT)	$	1,346	$	1,384	$	1,333	$	1,383
Sales volumes (thousands of MTs)	34		44		72		82

Net Sales - Three Months Ended


	Three Months Ended June 29, 2024		Changes Attributable to:				Three Months Ended June 28, 2025
(in millions)	Three Months Ended June 29, 2024		Price		Volume/Mix		Three Months Ended June 28, 2025
Net sales	$	60	$	(1)	$	(12)	$	47

Net sales of our Paperboard segment for the quarter ended June 28, 2025 decreased $13 million, or 22 percent, compared to the same prior year quarter. Sales prices and volumes decreased 3 percent and 23 percent, respectively, driven by mix, shifting customer dynamics associated with tariff uncertainty and increased competitive activity due to increased European Union imports and the start-up of new U.S. capacity.

Net Sales - Six Months Ended


	Six Months Ended June 29, 2024		Changes Attributable to:				Six Months Ended June 28, 2025
(in millions)	Six Months Ended June 29, 2024		Price		Volume/Mix		Six Months Ended June 28, 2025
Net sales	$	113	$	(4)	$	(13)	$	96

Net sales of our Paperboard segment for the six months ended June 28, 2025 decreased $17 million, or 15 percent, compared to the same prior year period. Sales prices and volumes decreased 4 percent and 12 percent, respectively, driven by mix, shifting customer dynamics associated with tariff uncertainty and increased competitive activity due to increased European Union imports and the start-up of new U.S. capacity.

Operating Income (Loss) - Three Months Ended


	Three Months Ended June 29, 2024			Gross Margin Changes Attributable to:												Three Months Ended June 28, 2025
(in millions, except percentages)				Sales Price			Sales Volume/Mix(a)			Cost			SG&A and other
Operating income (loss)	$	12		$	(1)		$	(5)		$	(4)		$	(2)		$	—
Operating margin %	20.0		%	(1.4)		%	(5.9)		%	(8.5)		%	(4.2)		%	—		%

(a)Computed based on contribution margin.

Operating results of our Paperboard segment for the quarter ended June 28, 2025 declined $12 million, or 100 percent, compared to the same prior year quarter driven by the lower sales, the impact of Temiscaming net custodial site costs and the one-time prior year recognition of $2 million in CEWS benefit claims.

Table of Contents

Operating Income (Loss) - Six Months Ended


	Six Months Ended June 29, 2024			Gross Margin Changes Attributable to:												Six Months Ended June 28, 2025
(in millions, except percentages)				Sales Price			Sales Volume/Mix(a)			Cost			SG&A and other
Operating income (loss)	$	20		$	(4)		$	(6)		$	(9)		$	(3)		$	(2)
Operating margin %	17.7		%	(3.0)		%	(4.3)		%	(9.4)		%	(3.1)		%	(2.1)		%

(a)Computed based on contribution margin.

Operating results of our Paperboard segment for the six months ended June 28, 2025 declined $22 million, or 110 percent, compared to the same prior year period driven by the lower sales, the impact of Temiscaming net custodial site costs and the one-time prior year recognition of $2 million in CEWS benefit claims.

High-Yield Pulp


	Three Months Ended				Six Months Ended
(in millions, unless otherwise stated)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Net sales	$	29	$	33	$	60	$	67
Operating income (loss)	$	(7)	$	1	$	(14)	$	—
Average sales prices ($ per MT)(a)	$	509	$	574	$	514	$	566
Sales volumes (thousands of MTs)(a)	42		45		90		95

(a)External sales only. During the quarters ended June 28, 2025 and June 29, 2024, the High-Yield Pulp segment sold 17,000 MTs and 16,000 MTs of high-yield pulp to the Paperboard segment for $7 million each period, respectively. During the six months ended June 28, 2025 and June 29, 2024, the High-Yield Pulp segment sold 33,000 MTs and 32,000 MTs of high-yield pulp to the Paperboard segment for $14 million and $13 million, respectively.

Net Sales - Three Months Ended


	Three Months Ended June 29, 2024		Changes Attributable to:				Three Months Ended June 28, 2025
(in millions)	Three Months Ended June 29, 2024		Price		Volume/Mix		Three Months Ended June 28, 2025
Net sales	$	33	$	(2)	$	(2)	$	29

Net sales of our High-Yield Pulp segment for the quarter ended June 28, 2025 decreased $4 million, or 12 percent, compared to the same prior year quarter. Sales prices and volumes decreased 11 percent and 7 percent, respectively, driven by lower demand, including in China where demand for all grades of market pulp were down, continued oversupply in China and the timing of shipments, primarily related to shipping challenges to customers in India.

Net Sales - Six Months Ended


	Six Months Ended June 29, 2024		Changes Attributable to:				Six Months Ended June 28, 2025
(in millions)	Six Months Ended June 29, 2024		Price		Volume/Mix		Six Months Ended June 28, 2025
Net sales	$	67	$	(5)	$	(2)	$	60

Net sales of our High-Yield Pulp segment for the six months ended June 28, 2025 decreased $7 million, or 10 percent, compared to the same prior year period. Sales prices and volumes decreased 9 percent and 5 percent, respectively, driven by lower demand, including in China where demand for all grades of market pulp were down, continued oversupply in China and the timing of shipments, primarily related to shipping challenges to customers in India.

Table of Contents

Operating Income (Loss) - Three Months Ended


	Three Months Ended June 29, 2024			Gross Margin Changes Attributable to:												Three Months Ended June 28, 2025
(in millions, except percentages)				Sales Price			Sales Volume/Mix(a)			Cost			SG&A and other
Operating income (loss)	$	1		$	(2)		$	(1)		$	(3)		$	(2)		$	(7)
Operating margin %	3.0		%	(6.3)		%	(3.7)		%	(10.3)		%	(6.8)		%	(24.1)		%

(a)Computed based on contribution margin.

Operating results of our High-Yield Pulp segment for the quarter ended June 28, 2025 declined $8 million compared to the same prior year quarter driven by the lower sales, higher logistics costs, the impact of Temiscaming net custodial site costs and the one-time prior year recognition of $2 million in CEWS benefit claims.

Operating Income (Loss) - Six Months Ended


	Six Months Ended June 29, 2024			Gross Margin Changes Attributable to:												Six Months Ended June 28, 2025
(in millions, except percentages)				Sales Price			Sales Volume/Mix(a)			Cost			SG&A and other
Operating income (loss)	$	—		$	(5)		$	—		$	(8)		$	(1)		$	(14)
Operating margin %	—		%	(8.1)		%	(0.3)		%	(13.3)		%	(1.6)		%	(23.3)		%

(a)Computed based on contribution margin.

Operating results of our High-Yield Pulp segment for the six months ended June 28, 2025 declined $14 million, or 100%, compared to the same prior year period driven by the lower sales, higher logistics costs, the impact of Temiscaming net custodial site costs and the one-time prior year recognition of $2 million in CEWS benefit claims. These negative impacts were partially offset by lower wood costs.

Corporate


	Three Months Ended				Six Months Ended
(in millions)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Operating loss	$	(15)	$	(15)	$	(41)	$	(26)

The Corporate operating loss for the quarter ended June 28, 2025 was flat compared to the same prior year quarter as lower variable compensation costs and a decrease in costs related to our ERP implementation were offset by unfavorable foreign exchange rates in the current quarter compared to favorable rates in the prior year quarter.

The Corporate operating loss for the six months ended June 28, 2025 declined $15 million compared to the same prior year period driven by first quarter non-cash environmental reserves charges of $12 million and unfavorable foreign exchange rates in the current period compared to favorable rates in the prior year period, partially offset by lower variable compensation costs. The environmental reserves charges are associated with recent developments at the Port Angeles, Washington, and Augusta, Georgia, remediation sites. The cash impact associated with the Augusta remediation site is expected in early 2027; the cash impact for the Port Angeles remediation site is not expected to begin before 2028, with outflows in the following three to five years.

Liquidity and Capital Resources

Overview

Cash flows from operations, primarily driven by operating results, have historically been our primary source of liquidity and capital resources. As operating cash flows can be negatively impacted by fluctuations in market prices for our commodity products and changes in demand for our products, we maintain a key focus on cash, managing working capital closely and optimizing the timing and level of our capital expenditures. We believe our future cash flows from operations, availability under our ABL Credit Facility and our ability to access the capital markets, if necessary or desirable, will be adequate to fund our operations and anticipated long-term funding requirements, including capital expenditures, defined benefit plan contributions and repayment of debt maturities.

Table of Contents

Our Board of Directors suspended our quarterly common stock dividend in September 2019. No dividends have been declared since. The declaration and payment of future common stock dividends, if any, will be at the discretion of our Board of Directors and will depend on our financial condition, results of operations, capital requirements and other factors that the Board of Directors deems relevant. In addition, our debt facilities place limitations on the declaration and payment of future dividends.

In January 2018, our Board of Directors authorized a $100 million common stock share buyback program. We have not repurchased shares under this program since 2018 and do not expect to utilize any of the remaining $60 million in unused authorization in the future.

Our liquidity and capital resources are summarized below:


(in millions, except ratios)	June 28, 2025			December 31, 2024
Cash and cash equivalents	$	71		$	125
Availability under the ABL Credit Facility(a)(b)	$	116		$	141
Total debt(b)	$	746		$	730
Stockholders’ equity	$	342		$	714
Total capitalization (total debt plus stockholders’ equity)	$	1,088		$	1,444
Debt to capital ratio	69		%	51		%

(a)Amounts available under the ABL Credit Facility fluctuate based on eligible accounts receivable and inventory levels. At June 28, 2025, we had $154 million of gross availability and net available borrowings of $116 million after taking into account outstanding letters of credit of $26 million. In addition to the availability under the ABL Credit Facility, we have $15 million available under our accounts receivable factoring line of credit in France.

(b)See Note 8—Debt and Finance Leases to our Financial Statements for further information.

As of June 28, 2025, we were in compliance with all financial and other covenants under our debt agreements.

Other Sources of Cash

SWEN Investment

In November 2024, we secured €30 million to be provided by SWEN in return for a 20 percent preferred equity interest in BioNova. We received €15 million from SWEN in 2024. Subsequent funding is contingent on the achievement of certain project milestones.

BioNova Term Loan

In November 2024, we entered into a credit agreement that authorizes up to €37 million in seven- and eight-year secured term loan tranches. As of June 28, 2025, no amounts were outstanding on the BioNova Term Loan.

Cash Requirements

Contractual Commitments

Our principal contractual commitments include standby letters of credit, surety bonds, guarantees, purchase obligations and leases. We utilize arrangements such as standby letters of credit and surety bonds to provide credit support for certain suppliers and vendors in case of their default on critical obligations, collateral for certain of our self-insurance programs and guarantees for the completion of our remediation of environmental liabilities. As part of our ongoing operations, we also periodically issue guarantees to third parties. Our primary purchase obligation payments relate to natural gas, electricity and wood chips purchase contracts. There have been no material changes outside the ordinary course of business to the purchase obligations presented in our 2024 Form 10-K during the six months ended June 28, 2025. See Note 18—Commitments and Contingencies to our Financial Statements for further information.

Table of Contents

Cash Flows


	Six Months Ended
(in millions)	June 28, 2025		June 29, 2024
Cash flows provided by (used in):
Operating activities	$	10	$	99

Investing activities	(75)		(58)

Financing activities	1		(1)

Cash provided by operating activities decreased $89 million compared to the prior year period primarily due to the decline in operating results, the one-time prior year proceeds of $39 million from the sale of our softwood lumber duty refund rights and lower income tax net refunds, partially offset by net cash inflows from working capital in the current year compared to net outflows in the prior year and lower interest paid on long-term debt due to the timing of payments.

Cash used in investing activities increased $17 million compared to the prior year period as higher custodial capital spend was partially offset by decreased strategic capital spend.

Cash inflows from financing activities increased $2 million compared to the prior year period due to higher net borrowings of long-term debt and the prior year payment of debt issuance costs, partially offset by higher net repayments of short-term financing and higher repurchases of common stock to satisfy tax withholding requirements.

Performance and Liquidity Indicators

The discussion below is presented to enhance the reader’s understanding of our operating performance, liquidity and ability to generate cash and satisfy rating agency and creditor requirements. This information includes the non-GAAP financial measures of EBITDA, adjusted EBITDA and adjusted free cash flow. These measures are not defined by GAAP and our discussion of them is not intended to conflict with or change any of our GAAP disclosures provided in this report.

We believe these non-GAAP financial measures provide useful information to our Board of Directors, management and investors regarding our financial condition and results of operations. Our management uses these non-GAAP financial measures to compare our performance to that of prior periods for trend analyses, to determine management incentive compensation and for budgeting, forecasting and planning purposes. Our management considers these non-GAAP financial measures, in addition to operating income, to be important in estimating our enterprise and stockholder values and for making strategic and operating decisions. In addition, analysts, investors and creditors use these non-GAAP financial measures when analyzing our operating performance, financial condition and cash-generating ability. We use EBITDA and adjusted EBITDA as performance measures and adjusted free cash flow as a liquidity measure.

We do not consider non-GAAP financial measures an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they may exclude significant expense and income items that are required by GAAP to be recognized in our Financial Statements. In addition, they reflect the exercise of management’s judgment about which expense and income items are excluded or included in determining these non-GAAP financial measures. To compensate for these limitations, reconciliations of our non-GAAP financial measures to their most directly comparable GAAP financial measures are provided below. Non-GAAP financial measures are not necessarily indicative of results that may be generated in future periods and should not be relied upon, in whole or part, in evaluating our financial condition, results of operations or future prospects.

Table of Contents

EBITDA and Adjusted EBITDA

EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted for items that management believes are not representative of our core operations.

Income (loss) from continuing operations is reconciled to EBITDA and Adjusted EBITDA from continuing operations by segment, as follows:


(in millions)	Cellulose Specialties		Biomaterials		Cellulose Commodities		Paperboard		High-Yield Pulp		Corporate		Total
Three Months Ended June 28, 2025
Income (loss) from continuing operations	$	29	$	1	$	(10)	$	(1)	$	(7)	$	(378)	$	(366)
Income from continuing operations attributable to redeemable noncontrolling interest	—		—		—		—		—		—		—
Income (loss) from continuing operations attributable to RYAM	29		1		(10)		(1)		(7)		(378)		(366)
Depreciation and amortization	17		—		7		6		—		1		31
Interest expense, net	—		—		—		—		—		23		23
Income tax expense	—		—		—		—		—		339		339
EBITDA-continuing operations attributable to RYAM	46		1		(3)		5		(7)		(15)		27


Indefinite suspension charges	—		—		1		—		—		—		1

Adjusted EBITDA-continuing operations attributable to RYAM	$	46	$	1	$	(2)	$	5	$	(7)	$	(15)	$	28

Three Months Ended June 29, 2024
Income (loss) from continuing operations	$	50	$	1	$	(21)	$	13	$	1	$	(36)	$	8
Income from continuing operations attributable to redeemable noncontrolling interest	—		—		—		—		—		—		—
Income (loss) from continuing operations attributable to RYAM	50		1		(21)		13		1		(36)		8
Depreciation and amortization	18

RAYONIER ADVANCED MATERIALS INC. 10-Q